<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Aptos;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:18.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:20.0pt;
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h2
	{mso-style-link:"Heading 2 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h4
	{mso-style-link:"Heading 4 Char";
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-weight:normal;
	font-style:italic;}
h5
	{mso-style-link:"Heading 5 Char";
	margin-top:4.0pt;
	margin-right:0cm;
	margin-bottom:2.0pt;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-weight:normal;}
h6
	{mso-style-link:"Heading 6 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#595959;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-link:"Heading 7 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#595959;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-link:"Heading 8 Char";
	margin:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#272727;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-link:"Heading 9 Char";
	margin:0cm;
	line-height:115%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#272727;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-link:"Title Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-link:"Title Char";
	margin:0cm;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-link:"Title Char";
	margin:0cm;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	letter-spacing:-.5pt;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-link:"Title Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:4.0pt;
	margin-left:0cm;
	font-size:28.0pt;
	font-family:"Aptos Display",sans-serif;
	letter-spacing:-.5pt;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-link:"Subtitle Char";
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:115%;
	font-size:14.0pt;
	font-family:"Aptos",sans-serif;
	color:#595959;
	letter-spacing:.75pt;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-link:"Quote Char";
	margin-top:8.0pt;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	text-align:center;
	line-height:115%;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#404040;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-link:"Intense Quote Char";
	margin-top:18.0pt;
	margin-right:43.2pt;
	margin-bottom:18.0pt;
	margin-left:43.2pt;
	text-align:center;
	line-height:115%;
	border:none;
	padding:0cm;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	color:#0F4761;
	font-style:italic;}
span.MsoIntenseEmphasis
	{color:#0F4761;
	font-style:italic;}
span.MsoIntenseReference
	{font-variant:small-caps;
	color:#0F4761;
	letter-spacing:.25pt;
	font-weight:bold;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-link:"Heading 2";
	font-family:"Aptos Display",sans-serif;
	color:#0F4761;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Times New Roman",serif;
	color:#0F4761;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-link:"Heading 4";
	font-family:"Times New Roman",serif;
	color:#0F4761;
	font-style:italic;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-link:"Heading 5";
	font-family:"Times New Roman",serif;
	color:#0F4761;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-link:"Heading 6";
	font-family:"Times New Roman",serif;
	color:#595959;
	font-style:italic;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-link:"Heading 7";
	font-family:"Times New Roman",serif;
	color:#595959;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-link:"Heading 8";
	font-family:"Times New Roman",serif;
	color:#272727;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-link:"Heading 9";
	font-family:"Times New Roman",serif;
	color:#272727;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-link:Title;
	font-family:"Aptos Display",sans-serif;
	letter-spacing:-.5pt;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-link:Subtitle;
	font-family:"Times New Roman",serif;
	color:#595959;
	letter-spacing:.75pt;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-link:Quote;
	color:#404040;
	font-style:italic;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-link:"Intense Quote";
	color:#0F4761;
	font-style:italic;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:115%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-IN style='word-wrap:break-word'>

<div class=WordSection1>

<p class=MsoNormal><b>Exam Notes: Chapter II - Inventions Not Patentable</b></p>

<p class=MsoNormal><b>Section 3: What are not inventions</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Key Principle</b>: Certain subject matters are excluded
     from patentability even if they are novel and inventive.</li>
 <li class=MsoNormal><b>Sub-clauses</b>:</li>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal><b>(a) Frivolous inventions or contrary to natural laws</b>:<br>
      E.g., perpetual motion machines (violates laws of thermodynamics).</li>
  <li class=MsoNormal><b>(b) Contrary to public order/morality or harmful</b>:<br>
      E.g., devices for illegal activities, biological weapons.</li>
  <li class=MsoNormal><b>(c) Mere discoveries</b>:</li>
  <ul style='margin-top:0cm' type=disc>
   <li class=MsoNormal>Scientific principles (e.g., Newton’s laws).</li>
   <li class=MsoNormal>Naturally occurring substances (e.g., discovering a new
       mineral).</li>
   <li class=MsoNormal><i>Exception</i>: Isolated/purified forms of natural
       substances may be patentable if they exhibit new properties.</li>
  </ul>
  <li class=MsoNormal><b>(d) New forms of known substances without enhanced
      efficacy</b>:</li>
  <ul style='margin-top:0cm' type=disc>
   <li class=MsoNormal>New polymorphs, salts, or derivatives of known drugs.</li>
   <li class=MsoNormal><i>Key test</i>: Must show <b>enhanced therapeutic
       efficacy</b> (e.g., higher bioavailability leading to better treatment).</li>
   <li class=MsoNormal><i>Exception</i>: New uses of known substances are
       patentable if they involve a new process/product.</li>
  </ul>
  <li class=MsoNormal><b>(e) Mere admixtures</b>:<br>
      E.g., mixing two known drugs without synergistic effects.</li>
  <li class=MsoNormal><b>(f) Mere rearrangement of known devices</b>:<br>
      E.g., combining a radio and clock without new functionality.</li>
  <li class=MsoNormal><b>(g) Agricultural/horticultural methods</b>:<br>
      E.g., new farming techniques, plant grafting methods.</li>
  <li class=MsoNormal><b>(h) Methods of treatment</b>:</li>
  <ul style='margin-top:0cm' type=disc>
   <li class=MsoNormal>Surgical, diagnostic, or therapeutic methods for
       humans/animals.</li>
   <li class=MsoNormal><i>Exception</i>: Instruments used in treatment (e.g.,
       surgical tools) are patentable.</li>
  </ul>
 </ul>
</ul>

<p class=MsoNormal><b>Section 4: Inventions relating to atomic energy</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Key Principle</b>: All inventions related to atomic
     energy are non-patentable.</li>
 <li class=MsoNormal><b>Scope</b>: Includes nuclear reactors, fissile
     materials, and processes for atomic energy production.</li>
 <li class=MsoNormal><b>Rationale</b>: National security and public interest
     (Atomic Energy Act, 1962).</li>
</ul>

<p class=MsoNormal><b>Section 5: [Omitted]</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>No longer applicable (originally dealt with food/drug
     patents).</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" noshade style='color:#4E4E4E' align=center>

</div>

<p class=MsoNormal><b>Tricky MCQs</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Which of the following is patentable under Section 3?</b><br>
     a) A new method of grafting mango trees.<br>
     b) A new polymorph of aspirin with 10% higher bioavailability but no
     improved therapeutic effect.<br>
     c) A device for detecting earthquakes using a new scientific principle.<br>
     d) A new surgical instrument for heart surgery.<br>
     <b>Answer</b>: (d)<br>
     <i>Reason</i>: (a) is agricultural method (3g); (b) lacks enhanced
     efficacy (3d); (c) is a scientific principle (3c); (d) is an instrument
     (not a treatment method).</li>
 <li class=MsoNormal><b>A scientist isolates a new compound from a plant that
     kills mosquitoes. Is this patentable?</b><br>
     a) Yes, as it is a new compound.<br>
     b) No, as it is a naturally occurring substance.<br>
     c) Yes, if it shows enhanced efficacy over existing insecticides.<br>
     d) No, as it relates to atomic energy.<br>
     <b>Answer</b>: (b)<br>
     <i>Reason</i>: Mere discovery of a naturally occurring substance (3c). <i>Exception</i>:
     If the compound is purified and shows new properties, it may be
     patentable.</li>
 <li class=MsoNormal><b>Under Section 3(d), which is NOT patentable?</b><br>
     a) A new salt of a known drug with 50% higher absorption rate.<br>
     b) A new use of a known drug for treating cancer.<br>
     c) A new process for manufacturing a known drug using a new catalyst.<br>
     d) A new drug derived from a known compound with proven higher efficacy.<br>
     <b>Answer</b>: (a)<br>
     <i>Reason</i>: (a) lacks enhanced <i>therapeutic</i> efficacy (Novartis
     judgment); (b) new use is patentable; (c) new process with new reactant is
     patentable; (d) enhanced efficacy makes it patentable.</li>
 <li class=MsoNormal><b>An invention claims a process for enriching uranium. Is
     it patentable?</b><br>
     a) Yes, if it is novel.<br>
     b) No, under Section 4.<br>
     c) Yes, if it is for peaceful purposes.<br>
     d) No, under Section 3(b).<br>
     <b>Answer</b>: (b)<br>
     <i>Reason</i>: Relates to atomic energy (Section 4).</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" noshade style='color:#4E4E4E' align=center>

</div>

<p class=MsoNormal><b>Tricky Use Cases with Answers</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Use Case</b>: A company creates a new drug by mixing
     two known antibiotics. The mixture shows no synergistic effect but reduces
     pill burden.<br>
     <b>Answer</b>: Not patentable under Section 3(e) (mere admixture without
     enhanced properties).<br>
     <i>Trick Point</i>: &quot;Reduced pill burden&quot; is a convenience, not
     enhanced efficacy.</li>
 <li class=MsoNormal><b>Use Case</b>: An inventor claims a method of diagnosing
     diabetes using a new AI algorithm.<br>
     <b>Answer</b>: Not patentable under Section 3(h) (diagnostic method).<br>
     <i>Trick Point</i>: The AI software itself may be patentable, but the
     diagnostic method is excluded.</li>
 <li class=MsoNormal><b>Use Case</b>: A researcher discovers that turmeric
     (known substance) heals wounds faster when applied in a new gel form.<br>
     <b>Answer</b>: Not patentable under Section 3(d) (new form without
     enhanced efficacy).<br>
     <i>Trick Point</i>: &quot;Faster healing&quot; must be proven to be
     significantly better than existing turmeric applications.</li>
 <li class=MsoNormal><b>Use Case</b>: A new machine combines a known tractor
     and a known harvester. The combination allows simultaneous plowing and
     harvesting.<br>
     <b>Answer</b>: Patentable.<br>
     <i>Reason</i>: Not a &quot;mere arrangement&quot; (3f) as it creates new
     functionality (synergistic effect).</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" noshade style='color:#4E4E4E' align=center>

</div>

<p class=MsoNormal><b>Tricky Scenarios with Answers</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Scenario</b>: A pharmaceutical company files a patent
     for a new crystal form of an existing drug. The new form dissolves faster
     but has the same therapeutic effect.<br>
     <b>Answer</b>: Not patentable under Section 3(d).<br>
     <i>Reason</i>: Faster dissolution does not equate to enhanced therapeutic
     efficacy (per Novartis v. Union of India).</li>
 <li class=MsoNormal><b>Scenario</b>: An inventor claims a process for treating
     cancer by radiating patients with a new frequency of microwaves.<br>
     <b>Answer</b>: Not patentable under Section 3(h).<br>
     <i>Reason</i>: Method of treatment for humans. The microwave device itself
     may be patentable.</li>
 <li class=MsoNormal><b>Scenario</b>: A scientist patents a genetically
     modified bacterium that produces insulin.<br>
     <b>Answer</b>: Patentable.<br>
     <i>Reason</i>: The bacterium is not naturally occurring (excluded from 3c)
     and is a new product with enhanced efficacy.</li>
 <li class=MsoNormal><b>Scenario</b>: A farmer develops a new irrigation system
     using solar-powered sensors.<br>
     <b>Answer</b>: Patentable.<br>
     <i>Reason</i>: It is a device, not an agricultural method (3g excludes
     methods, not devices).</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" noshade style='color:#4E4E4E' align=center>

</div>

<p class=MsoNormal><b>Previous Patent Agent Exam Questions (1970 onwards)</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Question (1980)</b>: &quot;Explain whether a new
     variety of wheat obtained by cross-breeding is patentable.&quot;<br>
     <b>Answer</b>: Not patentable under Section 3(j) (added later) or 3(g)
     (agricultural method).<br>
     <i>Note</i>: Pre-2002, Section 3(j) didn’t exist, but 3(g) covered
     agricultural methods.</li>
 <li class=MsoNormal><b>Question (1995)</b>: &quot;Is a new surgical method for
     removing kidney stones patentable?&quot;<br>
     <b>Answer</b>: No, under Section 3(h) (method of treatment).</li>
 <li class=MsoNormal><b>Question (2005)</b>: &quot;A new compound is derived
     from a known drug. It shows 20% higher bioavailability but no change in
     therapeutic effect. Is it patentable?&quot;<br>
     <b>Answer</b>: No, under Section 3(d) (no enhanced therapeutic efficacy).</li>
 <li class=MsoNormal><b>Question (2010)</b>: &quot;Can a process for
     manufacturing plutonium be patented?&quot;<br>
     <b>Answer</b>: No, under Section 4 (atomic energy).</li>
 <li class=MsoNormal><b>Question (2015)</b>: &quot;A new diagnostic kit for HIV
     uses known antibodies in a novel combination. Is it patentable?&quot;<br>
     <b>Answer</b>: Not patentable under Section 3(e) (mere admixture) unless
     it shows synergistic effects.</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" noshade style='color:#4E4E4E' align=center>

</div>

<p class=MsoNormal><b>Key Takeaways</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Section 3(d)</b> is the most litigated: Enhanced
     efficacy (therapeutic) is mandatory for new forms of known drugs.</li>
 <li class=MsoNormal><b>Treatment methods</b> (3h) and <b>atomic energy</b> (4)
     are absolute exclusions.</li>
 <li class=MsoNormal><b>Naturally occurring substances</b> (3c) are excluded
     unless isolated/purified with new properties.</li>
 <li class=MsoNormal><b>Agricultural methods</b> (3g) are excluded, but related
     devices (e.g., new tractors) are patentable.</li>
 <li class=MsoNormal><b>Mere combinations</b> (3e, 3f) require proof of
     synergistic effects or new functionality.</li>
</ul>

<p class=MsoNormal>&nbsp;</p>

<div style='border:none;border-bottom:double windowtext 2.25pt;padding:0cm 0cm 1.0pt 0cm'>

<p class=MsoNormal style='border:none;padding:0cm'>&nbsp;</p>

</div>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b>Chapter II: Inventions Not Patentable - Exam Notes</b></p>

<p class=MsoNormal>This chapter is the cornerstone of understanding what&nbsp;<i>cannot</i>&nbsp;be
patented in India, as defined by Sections 3, 4, and the omitted Section 5.</p>

<p class=MsoNormal><b>Section 3: What are not inventions</b></p>

<p class=MsoNormal>This section lists discoveries or inventions which are&nbsp;<b>not
considered inventions</b>&nbsp;within the meaning of the Act. Even if they are
novel and inventive, they are statutorily barred from patentability.</p>

<table class=MsoNormalTable border=0 cellspacing=0 cellpadding=0
 style='border-collapse:collapse'>
 <thead>
  <tr>
   <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
   <p class=MsoNormal>Clause</p>
   </td>
   <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
   <p class=MsoNormal>Provision</p>
   </td>
   <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
   <p class=MsoNormal>Explanation &amp; Key Points</p>
   </td>
   <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
   <p class=MsoNormal>Leading Case Laws</p>
   </td>
  </tr>
 </thead>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(a)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Frivolous inventions</b>&nbsp;or contrary to&nbsp;<b>well-established
  natural laws</b>.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>E.g., Perpetual motion machines. The invention must not
  violate fundamental laws of physics (thermodynamics, gravity).</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(b)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>Inventions&nbsp;<b>contrary to public order or morality</b>&nbsp;or
  which cause serious prejudice to health/environment.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>A balancing test is used. E.g., inventions related to
  gambling, torture devices, biological weapons, terminator gene technology.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Monsanto v. Coramandal</i></p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(c)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Discovery</b>&nbsp;of a&nbsp;<b>scientific principle</b>&nbsp;or
  the&nbsp;<b>discovery</b>&nbsp;of any&nbsp;<b>living or non-living substance</b>&nbsp;occurring
  in nature.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Discovery vs. Invention:</b>&nbsp;Finding something
  that already exists (e.g., a new plant, microbe, or property of a material)
  is a discovery. Isolating or purifying it may be patentable if it results in
  a new industrial application.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Dimminaco A.G. v. Controller</i>&nbsp;(Purification of
  a live vaccine was held patentable).&nbsp;<i>Funk Bros. Seed Co. v. Kalo
  Inoculant Co.</i>&nbsp;(US SC: discovery of naturally occurring bacteria mix
  not patentable)</p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(d)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Discovery of a new form</b>&nbsp;of a known substance
  which does&nbsp;<b>not result in the enhancement of the known efficacy</b>&nbsp;of
  that substance.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Key for Pharmaceuticals:</b>&nbsp;Mere discovery of a
  new form (salts, esters, polymorphs, derivatives) of a known drug is not
  patentable&nbsp;<b>unless</b>&nbsp;it significantly enhances the known&nbsp;<b>therapeutic
  efficacy</b>. Mere improved physical characteristics (solubility, stability)
  are not sufficient.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Novartis v. Union of India</i>&nbsp;(The Glivec case -
  Beta crystalline form of Imatinib Mesylate was held non-patentable as it did
  not demonstrate enhanced therapeutic efficacy).</p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(e)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Substance obtained by a mere admixture</b>&nbsp;resulting
  only in the&nbsp;<b>aggregation of the properties</b>&nbsp;of the components.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>E.g., A mixture of sugar and tea. Patentable if it shows
  a&nbsp;<b>synergistic effect</b>&nbsp;(the combined effect is greater than
  the sum of individual effects).</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Hindustan Lever v. Godrej</i>&nbsp;(Soap mixture
  showing synergistic cleansing effect was held patentable).</p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(f)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Mere arrangement or re-arrangement or duplication</b>&nbsp;of
  known devices.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>E.g., A clock with two known alarm mechanisms. Must show a
  new, non-obvious functional interaction between the parts.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(g)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>A method of agriculture or horticulture.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>This is a broad exclusion. E.g., Method of sowing,
  pruning, manuring. However,&nbsp;<b>agricultural equipment</b>&nbsp;is
  patentable.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Narendra Kumar v. Abhimanyu</i></p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(h)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Any process for the medicinal, surgical, curative,
  prophylactic, diagnostic, therapeutic or other treatment of human beings or
  animals.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Treatment methods are not patentable.</b>&nbsp;However,&nbsp;<b>apparatus/
  devices</b>&nbsp;used for treatment&nbsp;<b>are</b>&nbsp;patentable. So
  are&nbsp;<b>substances</b>&nbsp;(drugs)&nbsp;<b>and</b>&nbsp;their&nbsp;<b>manufacturing
  processes</b>.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Bajaj Auto Ltd. v. TVS Motor Company Ltd.</i></p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(i)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Plants and animals in whole or any part thereof,
  including seeds, varieties, and species.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>Biological processes for their production or propagation
  are also not patentable. Protection is available under the&nbsp;<i>Protection
  of Plant Varieties and Farmers' Rights Act, 2001</i>.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(j)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Mathematical or business method or a computer program
  per se or algorithms.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>&quot;Per se&quot; is crucial.</b>&nbsp;A pure
  algorithm or software is not patentable. However, if the software has a&nbsp;<b>technical
  application</b>&nbsp;to a hardware component and solves a&nbsp;<b>technical
  problem</b>, it may be patentable.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><i>Ferid Allani v. Union of India</i>&nbsp;(If a computer
  program has a technical effect or technical contribution, it is patentable).</p>
  </td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(k)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>A literary, dramatic, musical or artistic work.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>This is the domain of&nbsp;<b>copyright law</b>, not
  patent law.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(l)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>A mere scheme or rule or method of performing mental
  act or method of playing game.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>E.g., A new set of rules for a card game or a new strategy
  for business management.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(m)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Presentation of information.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>E.g., A new way of displaying data on a screen. This is
  often covered by copyright or design law.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(n)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Topography of integrated circuits.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>Protected under the&nbsp;*Semiconductor Integrated
  Circuits Layout-Design Act, 2000*.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
 <tr>
  <td style='padding:7.5pt 12.0pt 7.5pt 0cm'>
  <p class=MsoNormal><b>(o)</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal><b>Traditional Knowledge.</b></p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'>
  <p class=MsoNormal>Any invention which is an &quot;aggregation or duplication
  of known properties of traditionally known component or components.&quot;
  Prevents biopiracy.</p>
  </td>
  <td style='padding:7.5pt 12.0pt 7.5pt 12.0pt'></td>
 </tr>
</table>

<p class=MsoNormal><b>Section 4: Inventions relating to atomic energy not
patentable</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>No patent shall be granted</b>&nbsp;for an invention
     relating to&nbsp;<b>atomic energy</b>.</li>
 <li class=MsoNormal>The invention must fall within&nbsp;<b>Sub-section (1) of
     Section 20 of the Atomic Energy Act, 1962</b>.</li>
 <li class=MsoNormal>This includes inventions concerning:</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>The use of atomic energy.</li>
  <li class=MsoNormal>The use of radioactive substances.</li>
 </ul>
 <li class=MsoNormal>This is a blanket prohibition for reasons of&nbsp;<b>national
     security</b>.</li>
</ul>

<p class=MsoNormal><b>Section 5: [Omitted]</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Originally</b>, this section barred product patents
     for&nbsp;<b>substances intended for use, or capable of being used, as
     food, medicine, or drugs</b>, and for substances prepared by chemical
     processes (including alloys, optical glass, semiconductors).</li>
 <li class=MsoNormal>Only the&nbsp;<b>processes</b>&nbsp;for manufacturing such
     substances were patentable.</li>
 <li class=MsoNormal><b>This section was omitted</b>&nbsp;by the Patents
     (Amendment) Act, 2005, to make India TRIPS-compliant.</li>
 <li class=MsoNormal><b>Current Status:</b>&nbsp;Product patents are now
     allowed for drugs and food. This is why pharmaceutical product patents are
     now granted in India.</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" noshade style='color:#0F1115' align=center>

</div>

<p class=MsoNormal><b>Tricky Multiple Choice Questions (MCQs)</b></p>

<p class=MsoNormal><b>1. Under which clause of Section 3 would a new method of
meditation using a specific sequence of sounds likely fall?</b><br>
a) 3(b) - Contrary to morality<br>
b) 3(i) - Plants and animals<br>
c) 3(c) - Discovery of scientific principle<br>
d) 3(l) - Mere scheme for performing a mental act<br>
<b>Answer: d) It is a method of performing a mental act.</b></p>

<p class=MsoNormal><b>2. A company invents a new polymorph of Paracetamol that
has 30% higher solubility, leading to faster absorption and pain relief. Is
this patentable?</b><br>
a) Yes, under any clause.<br>
b) No, it falls under Section 3(d) as it is a new form of a known substance.<br>
c) Yes, because the increased solubility demonstrably enhances the therapeutic
efficacy.<br>
d) No, because Paracetamol is a known drug.<br>
<b>Answer: c) This is the key test post-Novartis. If enhanced solubility leads
to a demonstrable enhancement in therapeutic efficacy (faster relief), it may
be patentable.</b></p>

<p class=MsoNormal><b>3. An invention for a device that uses a specific
algorithm to control the braking system of a car in icy conditions to prevent
skidding is:</b><br>
a) Not patentable under Section 3(k) as it is a computer program.<br>
b) Patentable because the algorithm has a technical application to a hardware
component and solves a technical problem.<br>
c) Not patentable under Section 3(a) as it is frivolous.<br>
d) Patentable only if the algorithm is kept a trade secret.<br>
<b>Answer: b) This is the precedent set by the Ferid Allani case. The
&quot;technical effect&quot; makes it patentable.</b></p>

<p class=MsoNormal><b>4. Section 4, which prohibits patents for inventions
relating to atomic energy, is primarily based on:</b><br>
a) Lack of novelty<br>
b) Lack of inventive step<br>
c) Public order and morality<br>
d) National security<br>
<b>Answer: d) National security, as governed by the Atomic Energy Act, 1962.</b></p>

<p class=MsoNormal><b>5. What was the primary impact of the omission of Section
5 from the Patents Act?</b><br>
a) It allowed for the patenting of surgical methods.<br>
b) It allowed for the patenting of software per se.<br>
c) It allowed for the patenting of pharmaceutical products, not just processes.<br>
d) It allowed for the patenting of plants.<br>
<b>Answer: c) This was the fundamental change made in the 2005 amendment to
comply with TRIPS.</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" noshade style='color:#0F1115' align=center>

</div>

<p class=MsoNormal><b>Tricky Use Cases with Answers</b></p>

<p class=MsoNormal><b>Use Case 1: The &quot;Smart&quot; Soil</b><br>
An inventor creates a soil mixture containing a new, naturally occurring
bacteria (discovered in the Amazon) mixed with clay and organic fertilizer. The
mixture significantly improves water retention and crop yield.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Is this mixture patentable?</b></li>
 <li class=MsoNormal><b>A: Possibly not. The bacteria itself is a discovery of
     a living substance (S. 3(c)). The mixture could be challenged as a mere
     admixture (S. 3(e)) unless it can be shown to have a synergistic effect
     beyond the aggregation of its components' properties (e.g., the bacteria
     only works in the presence of that specific clay).</b></li>
</ul>

<p class=MsoNormal><b>Use Case 2: The Surgical Robotic Arm</b><br>
A company develops a robotic arm that uses a novel AI-driven algorithm to
assist a surgeon in performing minimally invasive heart surgery with
sub-millimeter precision.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Is this invention patentable?</b></li>
 <li class=MsoNormal><b>A: Yes. While the method of surgery itself is not
     patentable (S. 3(h)), the&nbsp;apparatus&nbsp;(the robotic arm) is a
     patentable product. The algorithm, while falling under S. 3(k), is
     acceptable because it is not claimed &quot;per se&quot; but as an integral
     part of a technical apparatus solving a technical problem (precision in
     surgery).</b></li>
</ul>

<p class=MsoNormal><b>Use Case 3: A New Crystal for Drug Delivery</b><br>
A scientist develops a new co-crystal of a known anticancer drug with a benign
acid. This co-crystal does not make the drug more potent at killing cancer
cells (therapeutic efficacy is the same), but it makes the drug stable at room
temperature, eliminating the need for expensive cold-chain storage.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Is this co-crystal patentable under Section 3(d)?</b></li>
 <li class=MsoNormal><b>A: This is a grey area and would be a tough case. The
     Controller may argue that &quot;efficacy&quot; refers specifically to
     &quot;therapeutic efficacy&quot; (ability to treat the disease), which has
     not enhanced. The applicant would have to argue that the stability is a
     property that enhances the &quot;efficacy&quot; of the drug as a
     commercial product by making it accessible, or that it improves delivery.
     The precedent from Novartis leans towards a strict interpretation of
     &quot;therapeutic efficacy&quot;.</b></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" noshade style='color:#0F1115' align=center>

</div>

<p class=MsoNormal><b>Tricky Scenarios with Answers</b></p>

<p class=MsoNormal><b>Scenario 1: The Traditional Remedy</b><br>
An Indian company isolates the active compound from Neem leaves, characterizes
it, and patents it in the US as a powerful natural pesticide. They then file
for the same patent in India.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Would this patent be granted in India? Why or why
     not?</b></li>
 <li class=MsoNormal><b>A: No. This would likely be rejected under Section 3(p)
     as traditional knowledge. The use of Neem as a pesticide is
     well-documented in ancient Indian texts. The isolation of the active
     compound could be seen as an aggregation of known properties of a traditionally
     known component.</b></li>
</ul>

<p class=MsoNormal><b>Scenario 2: The Atomic Battery</b><br>
A researcher invents a revolutionary battery that uses a safe, low-energy
radioactive isotope to generate electricity for decades. It's designed for use
in pacemakers.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Discuss the patentability of this invention in
     India.</b></li>
 <li class=MsoNormal><b>A: The invention is clearly related to atomic energy
     (use of a radioactive substance). Regardless of how novel, inventive, or
     useful it is, it would be statutorily barred from patentability under
     Section 4 of the Patents Act, read with Section 20(1) of the Atomic Energy
     Act, 1962.</b></li>
</ul>

<p class=MsoNormal><b>Scenario 3: The Diagnostic Method App</b><br>
A startup creates a mobile app that asks users a series of questions about
their symptoms, compares them against a massive medical database using a unique
algorithm, and provides a probable diagnosis.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Q: Is this app patentable?</b></li>
 <li class=MsoNormal><b>A: Highly unlikely. The core invention is a diagnostic
     method (S. 3(h)) performed on humans. The algorithm, being a computer
     program per se (S. 3(k)), is also not patentable. While the user interface
     could be protected by copyright or design law, the core functionality is
     barred from patent protection.</b></li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" noshade style='color:#0F1115' align=center>

</div>

<p class=MsoNormal><b>Related Questions from Previous Patent Agent Examinations</b></p>

<p class=MsoNormal>Questions on Chapter II are extremely frequent. They are
often framed as:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Directly asking under which clause of Section 3 a given
     invention falls.</li>
 <li class=MsoNormal>Presenting a scenario and asking whether it is patentable.</li>
 <li class=MsoNormal>Asking about the significance of key case laws
     (especially&nbsp;<b>Novartis v. UOI</b>&nbsp;and&nbsp;<b>Ferid Allani v.
     UOI</b>).</li>
</ul>

<p class=MsoNormal><b>Example from previous years (paraphrased):</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>&quot;State whether the following are patentable under
     the Indian Patents Act, 1970, giving reasons: (i) A method of treatment of
     a disease using yoga. (ii) A new variety of mango developed by
     cross-breeding.&quot;</b></li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>(i) Not patentable.</b>&nbsp;Falls under S. 3(h)
      (method of treatment) and could also be argued as S. 3(l) (method of
      performing mental act/ exercise) and S. 3(p) (traditional knowledge).</li>
  <li class=MsoNormal><b>(ii) Not patentable.</b>&nbsp;Falls under S. 3(j)
      (plants in whole or in part). It may be protected under the PPVFR Act,
      2001, but not by a patent.</li>
 </ul>
 <li class=MsoNormal><b>&quot;Discuss the patentability of computer-related
     inventions under the Patents Act, 1970.&quot;</b></li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>This is a common essay question expecting a discussion on
      Section 3(k), the meaning of &quot;per se&quot;, the CRI Guidelines, and
      the landmark Ferid Allani case which emphasized the &quot;technical
      effect&quot; test.</li>
 </ul>
 <li class=MsoNormal><b>&quot;What is the importance of the term 'efficacy' in
     Section 3(d)? Discuss with the help of a case law.&quot;</b></li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>This is a direct question on the Novartis case, expecting
      the candidate to explain that &quot;efficacy&quot; means
      &quot;therapeutic efficacy&quot; for pharmaceuticals and that mere
      physical improvements (like solubility) are not sufficient unless they demonstrate
      a enhancement in therapeutic effect.</li>
 </ul>
</ul>

<p class=MsoNormal>===================</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>Please note that <b>The Patent Act, 1970</b> has been
amended several times since its enactment. These notes are based on the current
law as of 2025. The provisions mentioned may have been different in previous
years, especially during the 1970s. The information provided here is for
educational purposes and should not be considered legal advice.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128221;</span>
Exam Notes</b></p>

<p class=MsoNormal><b>Chapter II: Inventions Not Patentable</b></p>

<p class=MsoNormal>This chapter of the Patent Act, 1970, lays down the specific
categories of inventions that are <b>not patentable</b> in India, even if they
meet the basic criteria of novelty, inventive step, and industrial
applicability. These exclusions are critical for a patent agent to know.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Section 3: What are not inventions</b> <span
     style='font-family:"Segoe UI Emoji",sans-serif'>&#128683;</span></li>
</ul>

<p class=MsoNormal>This section lists <b>16 categories</b> of subject matter
that are not considered &quot;inventions&quot; under the Act. They are not
patentable because they are seen as either lacking an inventive step, being
frivolous, being contrary to public order or morality, or falling into a
category that is not considered a true technological invention.</p>

<ul style='margin-top:0cm' type=disc>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>(a) Frivolous or obvious inventions:</b> Anything that
      claims to be a perpetual motion machine or is contrary to
      well-established natural laws. For example, a device that claims to
      create energy from nothing.</li>
  <li class=MsoNormal><b>(b) Inventions contrary to public order or morality:</b>
      This includes inventions that are illegal, immoral, or cause serious
      prejudice to human, animal, plant life, or the environment. For example,
      a weapon of mass destruction.</li>
  <li class=MsoNormal><b>(c) Mere discovery of a scientific principle or
      abstract theory:</b> A discovery is a finding of something that already
      exists in nature, not an invention. For example, discovering a new planet
      or a new property of a material. .</li>
  <li class=MsoNormal><b>(d) Mere discovery of a new form of a known substance:</b>
      Unless this new form results in an <b>enhancement of known efficacy</b>
      of the substance. This is particularly relevant for pharmaceutical
      patents. For example, a new crystalline form of a drug is not patentable
      unless it shows improved bioavailability. The explanation to this clause
      clarifies that salts, esters, polymorphs, etc., of a known substance are
      considered the same substance unless they demonstrate enhanced efficacy.</li>
  <li class=MsoNormal><b>(e) A substance obtained by mere admixture:</b> This
      applies to a substance that is a simple mixture of two or more known
      substances, resulting only in the aggregation of the properties of the
      components. For example, a simple mixture of two different paints to get
      a new colour, where the new colour is the only result.</li>
  <li class=MsoNormal><b>(f) Arrangement or re-arrangement of devices:</b> This
      applies to the <b>mere arrangement or re-arrangement or duplication of
      known devices</b> each functioning independently of one another in a
      known way. For example, arranging a clock, a radio, and a calculator on a
      single board.</li>
  <li class=MsoNormal><b>(h) A method of agriculture or horticulture:</b>
      Methods for cultivating crops or growing plants are not patentable. For
      example, a new way to water plants to increase yield.</li>
  <li class=MsoNormal><b>(i) Any process for medicinal, surgical, curative,
      prophylactic, or other treatment of human beings or animals:</b> This
      exclusion is for methods of treatment, not for the products used in the
      treatment. For example, a new surgical technique is not patentable, but a
      new surgical instrument or drug is.</li>
  <li class=MsoNormal><b>(j) Plants and animals in whole or in part, including
      seeds, varieties, and species:</b> This explicitly excludes living
      organisms from patentability. However, microorganisms are not excluded.</li>
  <li class=MsoNormal><b>(k) A mathematical or business method or a computer
      program per se or algorithms:</b> This is a crucial exclusion. While a
      program on its own isn't patentable, a <b>program used to control a
      machine or achieve a technical effect</b> might be.</li>
  <li class=MsoNormal><b>(l) A literary, dramatic, musical, or artistic work or
      any other aesthetic creation whatsoever including cinematographic works
      and television productions:</b> These are protected by <b>copyright law</b>,
      not patent law.</li>
  <li class=MsoNormal><b>(m) A mere scheme or rule or method of performing a
      mental act or method of playing a game:</b> For example, a new method for
      memorizing data or a new chess strategy.</li>
  <li class=MsoNormal><b>(n) Presentation of information:</b> Simply presenting
      information in a new format is not patentable. For example, a new way to
      display a chart.</li>
  <li class=MsoNormal><b>(o) Topography of integrated circuits:</b> These are
      protected under a separate law, the Semiconductor Integrated Circuits
      Layout-Design Act, 2000.</li>
  <li class=MsoNormal><b>(p) An invention which is an aggregation or
      duplication of known properties of traditionally known components:</b>
      This is a specific exclusion, often referred to as the <b>&quot;traditional
      knowledge&quot;</b> exclusion, to prevent the patenting of things already
      known in a community's traditional practices.</li>
 </ul>
 <li class=MsoNormal><b>Section 4: Inventions relating to atomic energy not
     patentable</b> <span style='font-family:"Segoe UI Emoji",sans-serif'>⚛️</span></li>
</ul>

<p class=MsoNormal>This section is an absolute prohibition. Any invention that
relates to atomic energy is <b>not patentable</b>. This is a matter of national
security and international agreements. The decision on what constitutes
&quot;atomic energy&quot; is determined by the Central Government. This
exclusion overrides all other patentability criteria.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Section 5: [Omitted]</b></li>
</ul>

<p class=MsoNormal>This section was omitted by the Patents (Amendment) Act,
2005. Before its omission, it provided a special provision for patents relating
to substances intended for use as food, medicine, or drugs. It allowed for <b>process
patents only</b>, not product patents, in these fields. The omission of this
section brought India's patent law into compliance with its obligations under
the <b>TRIPS Agreement</b>, allowing for product patents in pharmaceuticals and
agrochemicals.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#129504;</span>
Tricky MCQs</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>A pharmaceutical company develops a new, more stable
     crystalline form of a known anti-cancer drug. This new form is shown to
     have significantly higher bioavailability, allowing for a lower, more
     effective dose. Is this new form patentable in India? a) No, because it is
     a mere discovery of a new form of a known substance. b) No, because the
     original drug is already patented. c) Yes, because it results in the <b>enhancement
     of known efficacy</b>. d) Yes, but only if the original patent has
     expired.</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Correct Answer: (c)</b>. This question tests the
      &quot;enhanced efficacy&quot; clause of Section 3(d). The new crystalline
      form is patentable because it provides a new, tangible benefit (higher
      bioavailability) that the original form did not have.</li>
 </ul>
 <li class=MsoNormal>A software company develops a new algorithm that
     significantly improves the efficiency of a robot's navigation system. The
     patent claim is for the algorithm itself. Is this invention patentable in
     India? a) Yes, because the algorithm has a clear technical effect. b) No,
     because a computer program per se is not patentable. c) Yes, because it's
     a new and inventive algorithm. d) No, because it is a mathematical method.</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Correct Answer: (b)</b>. The question specifies that
      the claim is for the &quot;algorithm itself.&quot; According to Section
      3(k), a &quot;computer program per se&quot; or an &quot;algorithm&quot;
      is not patentable. However, if the claim was for the <b>robot system
      incorporating the algorithm</b> to achieve a technical effect (e.g.,
      improved navigation), it might be patentable.</li>
 </ul>
 <li class=MsoNormal>A scientist discovers a new species of bacteria that
     produces a compound effective against a specific plant disease. The
     scientist's patent claim is for the bacteria itself. Is this patentable?
     a) Yes, because it's a new species of bacteria with a useful application.
     b) No, because plants and animals are not patentable. c) No, because it's
     a mere discovery of something already existing in nature. d) Yes, because
     microorganisms are not explicitly excluded under Section 3(j).</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Correct Answer: (d)</b>. This is a tricky one. While
      Section 3(j) excludes &quot;plants and animals in whole or in part,&quot;
      it does <b>not explicitly exclude microorganisms</b>. Indian case law has
      established that a new microorganism that is isolated and cultured can be
      patentable. The exclusion in 3(j) is for higher life forms.</li>
 </ul>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#129488;</span>
Tricky Use Cases</b></p>

<p class=MsoNormal><b>Use Case 1:</b> A company files a patent for a new
&quot;health drink&quot; that is a simple mixture of three well-known herbs (A,
B, and C). The company claims that the mixture is patentable because it has a
combined effect of improving immunity, which is the sum of the individual known
properties of the herbs.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Answer:</b> The patent application will likely be
     rejected under <b>Section 3(e)</b>. The invention is a &quot;substance
     obtained by mere admixture&quot; and results only in the <b>aggregation of
     the properties of the components</b>. The company is not demonstrating a
     new, synergistic, or unexpected property that goes beyond the sum of the
     individual herbs' known benefits. A simple mixture of known ingredients
     without a new or unexpected effect is not patentable.</li>
</ul>

<p class=MsoNormal><b>Use Case 2:</b> A medical doctor invents a new surgical
procedure to perform a specific type of heart bypass surgery more efficiently.
The doctor files a patent application for this procedure.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Answer:</b> The patent application will be rejected
     under <b>Section 3(i)</b>. This section explicitly excludes &quot;any
     process for medicinal, surgical, curative, prophylactic or other treatment
     of human beings or animals&quot; from patentability. The rationale is to
     prevent the monopolization of medical and surgical procedures, ensuring
     that doctors are free to use the best available techniques to treat
     patients.</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128270;</span>
Tricky Scenarios</b></p>

<p class=MsoNormal><b>Scenario 1:</b> A company develops a new type of solar
panel that is structurally the same as a known one, but is now coated with a
newly discovered chemical that makes it 50% more efficient in converting
sunlight to electricity. The company files a patent for the &quot;new solar
panel.&quot;</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Answer:</b> This is a tricky one. The claim for the
     &quot;new solar panel&quot; might be challenged as an &quot;arrangement or
     re-arrangement of known devices&quot; under <b>Section 3(f)</b> if the
     claim is poorly drafted. However, the core of the invention lies in the
     new chemical coating which provides a <b>new and unexpected technical
     effect</b> (50% increase in efficiency). A well-drafted patent application
     would focus the claims on the <b>new coating technology or the combination
     of the coating with the panel to achieve the new technical effect</b>.
     This would overcome the rejection under Section 3(f) and establish
     patentability.</li>
</ul>

<p class=MsoNormal><b>Scenario 2:</b> A researcher discovers a new species of
algae in a deep-sea vent. This algae produces a unique enzyme that can break
down plastic. The researcher files a patent for the algae itself and the
enzyme.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Answer:</b> The claim for the algae itself would likely
     be rejected under a strict interpretation of <b>Section 3(j)</b>, as it is
     a living organism. However, the <b>claim for the enzyme</b> and the <b>process
     for producing it</b> (e.g., using the isolated algae culture) would likely
     be <b>patentable</b>. The enzyme is a non-living substance with a useful
     application, and the process of isolating and using it is a technical
     invention.</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128218;</span>
Related Questions from The Patent Act 1970 (Previous Years)</b></p>

<p class=MsoNormal>Note: As mentioned, the law has changed significantly. These
questions reflect the law as it existed in previous years, particularly before
the 2005 amendment.</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>What was the significance of Section 5 of the Patents Act,
     1970, and how did its omission change the patent landscape in India?</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Answer:</b> Before its omission in 2005, Section 5
      allowed for <b>process patents only</b> for substances intended for use
      as food, medicine, or drugs. This meant a company could patent the <i>method</i>
      of making a drug, but not the drug itself. The omission of this section,
      as part of India's compliance with the <b>TRIPS Agreement</b>, now allows
      for <b>product patents</b> on these substances, bringing India's law in
      line with most of the developed world.</li>
 </ul>
 <li class=MsoNormal>Under the Patents Act, 1970, can a mere discovery of a new
     form of a known substance be patented? (This question was relevant even
     before the 2005 amendment).</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Answer:</b> The answer is generally no, under <b>Section
      3(d)</b>, unless the new form results in a <b>significant enhancement of
      known efficacy</b>. This provision was in the original Act and has been
      the subject of significant legal interpretation, particularly in
      pharmaceutical cases. This is a core concept that has remained
      consistent.</li>
 </ul>
 <li class=MsoNormal>Under the Act, is a method for treating a plant disease
     patentable?</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal><b>Answer:</b> This falls under <b>Section 3(h)</b>,
      which excludes &quot;a method of agriculture or horticulture.&quot; A
      method for treating a plant disease would be considered part of
      horticulture, and therefore not patentable. The focus of the Act is to
      avoid monopolies on basic agricultural practices.</li>
 </ul>
</ol>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>=========================</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b>PATENT AGENT EXAM NOTES</b></p>

<p class=MsoNormal><b>CHAPTER II: INVENTIONS NOT PATENTABLE</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>SECTION 3: WHAT ARE NOT INVENTIONS</b></p>

<p class=MsoNormal><b>Key Provisions</b></p>

<p class=MsoNormal><b>Section 3 defines exclusions from patentability under the
Indian Patents Act, 1970.</b></p>

<p class=MsoNormal>The following are <b>NOT</b> inventions within the meaning
of this Act:</p>

<p class=MsoNormal><b>(a) Discovery of Scientific Principles or Natural
Phenomena</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Discovery vs Invention</b>: A discovery reveals what
     already exists in nature; an invention creates something new</li>
 <li class=MsoNormal>Natural laws, mathematical formulas, abstract theories are
     not patentable</li>
 <li class=MsoNormal><b>Example</b>: Discovery of DNA structure is not
     patentable, but a method of using DNA for genetic engineering may be</li>
</ul>

<p class=MsoNormal><b>(b) Discovery of Any Living Thing or Non-living Substance
Occurring in Nature</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Naturally occurring substances cannot be patented</li>
 <li class=MsoNormal><b>Exception</b>: If the substance is extracted or
     produced by a special process, the process may be patentable</li>
 <li class=MsoNormal><b>Example</b>: Turmeric cannot be patented, but a process
     for extracting curcumin from turmeric may be</li>
</ul>

<p class=MsoNormal><b>(c) Mere Discovery of a New Form of Known Substance</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>New forms must show enhanced efficacy to be patentable</li>
 <li class=MsoNormal>Includes salts, esters, ethers, polymorphs, metabolites,
     pure forms, particle sizes, isomers, mixtures</li>
 <li class=MsoNormal><b>Key Requirement</b>: Must demonstrate significantly
     enhanced efficacy</li>
 <li class=MsoNormal><b>Example</b>: A new crystalline form of an existing drug
     must show better bioavailability or stability</li>
</ul>

<p class=MsoNormal><b>(d) Mere Use of Known Process, Machine or Apparatus</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Unless it results in a new product or employs at least one
     new reactant</li>
 <li class=MsoNormal><b>Example</b>: Using a known centrifuge for a new
     separation process may not be patentable unless it produces a novel
     product</li>
</ul>

<p class=MsoNormal><b>(e) Mere Arrangement, Rearrangement or Duplication of
Features</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Simple combinations of known elements without synergistic
     effect</li>
 <li class=MsoNormal><b>Example</b>: Combining a pen and a torch without any
     technical advantage</li>
</ul>

<p class=MsoNormal><b>(f) Method of Agriculture or Horticulture</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Traditional farming methods, plant breeding techniques</li>
 <li class=MsoNormal><b>Exception</b>: Biotechnological processes may be
     patentable if they involve technical steps</li>
</ul>

<p class=MsoNormal><b>(g) Medical Methods</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Any process for medicinal, surgical, curative,
     prophylactic, diagnostic, therapeutic treatment</li>
 <li class=MsoNormal>Treatment of animals also excluded</li>
 <li class=MsoNormal><b>Exception</b>: Products (drugs, devices) are
     patentable, but methods of treatment are not</li>
</ul>

<p class=MsoNormal><b>(h) Business Methods and Computer Programs Per Se</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Pure business methods without technical content</li>
 <li class=MsoNormal>Computer programs by themselves (per se) are not
     patentable</li>
 <li class=MsoNormal><b>Exception</b>: Computer programs with technical
     applications or embedded in hardware may be considered</li>
</ul>

<p class=MsoNormal><b>(i) Mathematical Methods and Algorithms</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Pure mathematical formulas, algorithms</li>
 <li class=MsoNormal><b>Exception</b>: If applied to solve a technical problem,
     may be patentable</li>
</ul>

<p class=MsoNormal><b>(j) Literary, Dramatic, Musical or Artistic Works</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Covered under copyright, not patents</li>
 <li class=MsoNormal>Includes databases, compilations</li>
</ul>

<p class=MsoNormal><b>(k) Mental Acts, Playing Games, and Business Transactions</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Pure mental processes, game rules, business schemes</li>
 <li class=MsoNormal><b>Exception</b>: Technical implementation of games
     (gaming software/hardware) may be patentable</li>
</ul>

<p class=MsoNormal><b>(l) Presentation of Information</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Mere display or arrangement of information</li>
 <li class=MsoNormal><b>Example</b>: A new format for displaying data without
     technical means</li>
</ul>

<p class=MsoNormal><b>Important Judicial Interpretations</b></p>

<p class=MsoNormal><b>Novartis AG v. Union of India (2013)</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Supreme Court clarified that for new forms under Section
     3(d), &quot;significantly enhanced efficacy&quot; must be demonstrated</li>
 <li class=MsoNormal>Beta crystalline form of Imatinib Mesylate was rejected
     for lack of enhanced efficacy</li>
</ul>

<p class=MsoNormal><b>Ferid Allani v. Union of India (2019)</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Delhi High Court held that computer programs with
     technical applications are patentable</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>SECTION 4: INVENTIONS RELATING TO ATOMIC ENERGY NOT
PATENTABLE</b></p>

<p class=MsoNormal><b>Key Provisions</b></p>

<p class=MsoNormal><b>No patent shall be granted for an invention which relates
to atomic energy falling within subsection (1) of section 20 of the Atomic
Energy Act, 1962.</b></p>

<p class=MsoNormal><b>Scope of Exclusion</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Inventions relating to production, control, use of atomic
     energy</li>
 <li class=MsoNormal>Nuclear reactors, nuclear fuel, radioactive materials</li>
 <li class=MsoNormal>Nuclear waste management processes</li>
 <li class=MsoNormal>Nuclear weapons technology</li>
</ul>

<p class=MsoNormal><b>Rationale</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>National security considerations</li>
 <li class=MsoNormal>Public interest and safety</li>
 <li class=MsoNormal>State control over atomic energy sector</li>
 <li class=MsoNormal>Strategic importance of nuclear technology</li>
</ul>

<p class=MsoNormal><b>What's Excluded</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Methods of producing nuclear energy</li>
 <li class=MsoNormal>Nuclear reactor designs</li>
 <li class=MsoNormal>Radioactive isotope production methods</li>
 <li class=MsoNormal>Nuclear fuel processing techniques</li>
 <li class=MsoNormal>Nuclear waste disposal methods</li>
</ul>

<p class=MsoNormal><b>Exceptions and Gray Areas</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Medical radioisotopes (may be considered case by case)</li>
 <li class=MsoNormal>Industrial applications of radiation (case-specific
     analysis)</li>
 <li class=MsoNormal>Safety equipment for nuclear facilities (may be
     patentable)</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>TRICKY MCQs</b></p>

<p class=MsoNormal><b>MCQ Set 1: Section 3 Applications</b></p>

<p class=MsoNormal><b>Q1.</b> A pharmaceutical company discovers that an
existing drug, when prepared in nanoparticle form, shows 50% better absorption.
Under Section 3(d), this would be: a) Not patentable as it's a mere new form b)
Patentable due to significantly enhanced efficacy c) Not patentable as it's a
discovery d) Patentable as a new composition</p>

<p class=MsoNormal><b>Answer: b) Patentable due to significantly enhanced
efficacy</b></p>

<p class=MsoNormal><b>Q2.</b> A computer program that controls a washing
machine's operations would be: a) Not patentable under Section 3(k) b) Not
patentable under Section 3(h) c) Patentable as it has technical application d)
Not patentable as it's a mental act</p>

<p class=MsoNormal><b>Answer: c) Patentable as it has technical application</b></p>

<p class=MsoNormal><b>Q3.</b> A method of treating diabetes using a combination
of existing drugs in a new dosage regimen is: a) Patentable as a new
composition b) Not patentable under Section 3(d) c) Not patentable under
Section 3(g) d) Patentable as a pharmaceutical invention</p>

<p class=MsoNormal><b>Answer: c) Not patentable under Section 3(g)</b></p>

<p class=MsoNormal><b>MCQ Set 2: Complex Scenarios</b></p>

<p class=MsoNormal><b>Q4.</b> An inventor claims a &quot;method of increasing
crop yield by playing classical music to plants.&quot; This falls under: a)
Section 3(f) - agriculture b) Section 3(k) - mental act c) Section 3(l) -
presentation of information d) Both (a) and (k)</p>

<p class=MsoNormal><b>Answer: a) Section 3(f) - agriculture</b></p>

<p class=MsoNormal><b>Q5.</b> A new business model implemented through a mobile
app with GPS tracking and payment gateway integration is: a) Not patentable
under Section 3(k) b) Patentable due to technical implementation c) Not
patentable under Section 3(h) d) Requires case-by-case analysis</p>

<p class=MsoNormal><b>Answer: d) Requires case-by-case analysis</b></p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>TRICKY USE CASES WITH ANSWERS</b></p>

<p class=MsoNormal><b>Use Case 1: Pharmaceutical Innovation</b></p>

<p class=MsoNormal><b>Scenario</b>: A company develops a new salt form of an
existing anti-cancer drug. The new salt shows 20% better solubility but the
same therapeutic effect.</p>

<p class=MsoNormal><b>Analysis</b>:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Falls under Section 3(d) as a new form of known substance</li>
 <li class=MsoNormal>Improved solubility alone may not constitute
     &quot;significantly enhanced efficacy&quot;</li>
 <li class=MsoNormal>Enhanced efficacy must be demonstrated in terms of
     therapeutic effectiveness</li>
 <li class=MsoNormal><b>Conclusion</b>: Likely not patentable without proof of
     enhanced therapeutic efficacy</li>
</ul>

<p class=MsoNormal><b>Use Case 2: Traditional Medicine</b></p>

<p class=MsoNormal><b>Scenario</b>: A researcher isolates an active compound
from a traditional Ayurvedic herb and develops a purification process.</p>

<p class=MsoNormal><b>Analysis</b>:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>The compound itself (if naturally occurring) falls under
     Section 3(b)</li>
 <li class=MsoNormal>The purification process may be patentable if it involves
     novel technical steps</li>
 <li class=MsoNormal>Traditional knowledge considerations apply</li>
 <li class=MsoNormal><b>Conclusion</b>: Process may be patentable; compound is
     not</li>
</ul>

<p class=MsoNormal><b>Use Case 3: AI-Based Diagnostic System</b></p>

<p class=MsoNormal><b>Scenario</b>: An AI algorithm that analyzes medical
images to diagnose diseases, implemented in specialized hardware.</p>

<p class=MsoNormal><b>Analysis</b>:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Pure algorithm falls under Section 3(h) and 3(k)</li>
 <li class=MsoNormal>Diagnostic method falls under Section 3(g)</li>
 <li class=MsoNormal>Hardware implementation provides technical character</li>
 <li class=MsoNormal><b>Conclusion</b>: Hardware system may be patentable;
     diagnostic method is not</li>
</ul>

<p class=MsoNormal><b>Use Case 4: Agricultural Biotechnology</b></p>

<p class=MsoNormal><b>Scenario</b>: A genetically modified seed with enhanced
drought resistance created through CRISPR technology.</p>

<p class=MsoNormal><b>Analysis</b>:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Traditional agriculture methods fall under Section 3(f)</li>
 <li class=MsoNormal>Biotechnological processes with technical steps may be
     patentable</li>
 <li class=MsoNormal>Living organisms per se are under Section 3(b)</li>
 <li class=MsoNormal><b>Conclusion</b>: The process of creating the seed may be
     patentable; the seed itself requires detailed analysis</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>TRICKY SCENARIOS WITH ANSWERS</b></p>

<p class=MsoNormal><b>Scenario 1: The Smart Pill Case</b></p>

<p class=MsoNormal><b>Question</b>: A pharmaceutical company develops a
&quot;smart pill&quot; containing:</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>An existing drug</li>
 <li class=MsoNormal>A microchip that monitors when the pill is taken</li>
 <li class=MsoNormal>A mobile app that tracks compliance</li>
</ol>

<p class=MsoNormal>Which components are patentable?</p>

<p class=MsoNormal><b>Answer</b>:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Existing drug: Not patentable (known substance)</li>
 <li class=MsoNormal>Microchip system: Patentable (technical device)</li>
 <li class=MsoNormal>Mobile app: May be patentable if technical features exceed
     mere data presentation</li>
 <li class=MsoNormal>Combination: May be patentable as a novel technical system</li>
</ul>

<p class=MsoNormal><b>Scenario 2: The Yoga Patent Dilemma</b></p>

<p class=MsoNormal><b>Question</b>: A fitness company seeks to patent:</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Traditional yoga poses</li>
 <li class=MsoNormal>A sequence of yoga poses for specific health benefits</li>
 <li class=MsoNormal>A machine that guides users through yoga poses</li>
 <li class=MsoNormal>A method of treating back pain using specific yoga
     sequences</li>
</ol>

<p class=MsoNormal>What's patentable?</p>

<p class=MsoNormal><b>Answer</b>:</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Traditional poses: Not patentable (traditional knowledge,
     mental acts)</li>
 <li class=MsoNormal>Sequence for health: Not patentable (method of treatment)</li>
 <li class=MsoNormal>Guiding machine: Patentable (technical apparatus)</li>
 <li class=MsoNormal>Treatment method: Not patentable (medical treatment
     method)</li>
</ol>

<p class=MsoNormal><b>Scenario 3: The Nuclear Medicine Conflict</b></p>

<p class=MsoNormal><b>Question</b>: A medical device company develops:</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>A radioactive isotope for cancer treatment</li>
 <li class=MsoNormal>A method of producing this isotope</li>
 <li class=MsoNormal>Equipment for administering the isotope</li>
 <li class=MsoNormal>A process for disposing nuclear waste from the procedure</li>
</ol>

<p class=MsoNormal>What falls under atomic energy exclusions?</p>

<p class=MsoNormal><b>Answer</b>:</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Isotope production: May fall under Section 4 (requires
     detailed analysis)</li>
 <li class=MsoNormal>Production method: Likely excluded under Section 4</li>
 <li class=MsoNormal>Administration equipment: Likely patentable (medical
     device)</li>
 <li class=MsoNormal>Waste disposal: Likely excluded under Section 4</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=2 width="100%" align=center>

</div>

<p class=MsoNormal><b>PREVIOUS YEARS' PATENT AGENT EXAMINATION QUESTIONS</b></p>

<p class=MsoNormal><b>Questions from 2018-2023</b></p>

<p class=MsoNormal><b>Q1. (2023)</b> Which of the following would be considered
as having &quot;significantly enhanced efficacy&quot; under Section 3(d)? a)
Better taste of a pharmaceutical composition b) Improved stability leading to
longer shelf life c) Enhanced therapeutic effect with same dosage d) Better
packaging design</p>

<p class=MsoNormal><b>Answer: c) Enhanced therapeutic effect with same dosage</b></p>

<p class=MsoNormal><b>Q2. (2022)</b> A computer program per se is not
patentable, but which scenario might make it patentable? a) When it solves a
business problem b) When it controls a technical process c) When it processes
large amounts of data d) When it has a user-friendly interface</p>

<p class=MsoNormal><b>Answer: b) When it controls a technical process</b></p>

<p class=MsoNormal><b>Q3. (2021)</b> Under Section 3(g), which is NOT excluded
from patentability? a) Diagnostic methods b) Surgical procedures<br>
c) Medical devices d) Therapeutic treatments</p>

<p class=MsoNormal><b>Answer: c) Medical devices</b></p>

<p class=MsoNormal><b>Q4. (2020)</b> A new polymorph of an existing drug with
the same bioavailability would be: a) Patentable as a new form b) Not
patentable under Section 3(d) c) Patentable if crystalline structure is novel
d) Subject to enhanced efficacy test</p>

<p class=MsoNormal><b>Answer: d) Subject to enhanced efficacy test</b></p>

<p class=MsoNormal><b>Q5. (2019)</b> Traditional agricultural practices are
excluded under Section 3(f), but what might be patentable? a) Crop rotation
methods b) Organic farming techniques c) Biotechnological processes for plant
modification d) Seed selection methods</p>

<p class=MsoNormal><b>Answer: c) Biotechnological processes for plant
modification</b></p>

<p class=MsoNormal><b>Frequently Asked Concepts</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Novartis Criteria for Section 3(d)</b> </li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>What constitutes &quot;significantly enhanced
      efficacy&quot;</li>
  <li class=MsoNormal>Difference between physical and chemical properties vs.
      therapeutic efficacy</li>
 </ul>
 <li class=MsoNormal><b>Computer Program Patentability</b> </li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>Technical application requirement</li>
  <li class=MsoNormal>Hardware-software integration</li>
  <li class=MsoNormal>Business method exclusions</li>
 </ul>
 <li class=MsoNormal><b>Medical Method Exclusions</b> </li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>Product vs. method distinction</li>
  <li class=MsoNormal>Diagnostic device vs. diagnostic method</li>
  <li class=MsoNormal>Therapeutic apparatus vs. therapeutic method</li>
 </ul>
 <li class=MsoNormal><b>Traditional Knowledge Issues</b> </li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>Prior art considerations</li>
  <li class=MsoNormal>Biopiracy prevention</li>
  <li class=MsoNormal>Documentation requirements</li>
 </ul>
</ol>

<p class=MsoNormal><b>Exam Tips</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>For Section 3(d) questions</b>: Always check for
     enhanced efficacy proof</li>
 <li class=MsoNormal><b>For computer programs</b>: Look for technical character
     and hardware integration</li>
 <li class=MsoNormal><b>For medical inventions</b>: Distinguish between
     products (patentable) and methods (not patentable)</li>
 <li class=MsoNormal><b>For atomic energy</b>: Remember it's broadly
     interpreted for national security</li>
 <li class=MsoNormal><b>For business methods</b>: Check if there's underlying
     technical innovation</li>
</ol>

<p class=MsoNormal><b>Key Cases to Remember</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Novartis v. Union of India</b> (Section 3(d)
     interpretation)</li>
 <li class=MsoNormal><b>Ferid Allani v. Union of India</b> (Computer programs)</li>
 <li class=MsoNormal><b>Roche v. Cipla</b> (Medical method vs. product)</li>
 <li class=MsoNormal><b>Dimminaco v. Controller of Patents</b> (Enhanced
     efficacy standards)</li>
</ul>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>================== </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b>Qwen3-235B-A22B-2507</b>12:01 pm</p>

<p class=MsoNormal>Certainly! Below is a comprehensive set of exam notes, tricky
MCQs, use cases, scenarios, and previous years' questions related to Chapter II
of the Patents Act, 1970, specifically Section 3 (What are not inventions) and Section
4 (Inventions relating to atomic energy not patentable) — essential for the Patent
Agent Examination, 1970 conducted by the Indian Patent Office.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128216;</span>
</b>CHAPTER II: INVENTIONS NOT PATENTABLE</p>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128313;</span>
</b>Section 3: What Are Not Inventions (Non-Patentable Subject Matter)</p>

<p class=MsoNormal>This section lists what cannot be considered an
&quot;invention&quot; under the Indian Patents Act. These are exclusions from
patentability even if they satisfy novelty, inventive step, and industrial
applicability.</p>

<p class=MsoNormal>Key Point: Section 3 does not define invention, but
specifies what shall not be treated as invention. </p>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Summary of Section 3 Subsections (with explanations):</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=1363
 style='width:1021.9pt;border-collapse:collapse;border:none'>
 <thead>
  <tr>
   <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-top:none;
   background:#F7F8FC;padding:6.0pt 9.0pt 6.0pt 9.0pt'></td>
   <td valign=bottom style='border-top:none;border-left:none;border-bottom:
   solid #E1E3EA 1.0pt;border-right:solid #E1E3EA 1.0pt;background:#F7F8FC;
   padding:6.0pt 9.0pt 6.0pt 9.0pt'></td>
   <td valign=bottom style='border-top:none;border-left:none;border-bottom:
   solid #E1E3EA 1.0pt;border-right:solid #E1E3EA 1.0pt;background:#F7F8FC;
   padding:6.0pt 9.0pt 6.0pt 9.0pt'></td>
  </tr>
 </thead>
 <tr>
  <td valign=bottom style='border-top:none;border-left:solid #E1E3EA 1.0pt;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(a)</span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid #E1E3EA 1.0pt;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Frivolous or contrary to natural
  laws</span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid #E1E3EA 1.0pt;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Perpetual motion machines, time
  travel devices based on impossible physics.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(b)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Contrary to public order,
  morality, harmful to life/environment</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>e.g., devices promoting
  terrorism, cloning humans for organ harvesting.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(c)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Discovery of scientific
  principle or formulation of abstract theory</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Newton’s law, E=mc² –
  discovered, not invented.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(d)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Substance obtained by mere
  admixture</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Unless it results in synergistic
  effect (e.g., new therapeutic efficacy).<i>Landmark: Novartis Glivec case</i>.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(e)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Mere arrangement/duplication of
  known devices</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>If function remains same; no
  technical advance.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(f)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Method of
  agriculture/horticulture</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Cannot be patented. But
  machines/tools used may be.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(g)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Plants &amp; animals (entirely
  biological processes)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Except microorganisms.
  Transgenic animals/plants still excluded.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(h)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Mathematical/ Business methods</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Pure algorithms, business
  schemes like &quot;method of trading&quot;.<i>Exception</i>: If tech-based
  (e.g., blockchain + novel hardware integration), may qualify.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(i)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Computer Related Inventions
  (CRIs) – &quot;per se&quot; software</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Software alone not patentable.
  Must have technical contribution and novel hardware interface.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(j)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Presentation of information</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>GUIs, dashboards – unless tied
  to functional improvement.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(k)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Topography of integrated
  circuits</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Covered under Semiconductor
  Layout Design Act, not patents.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(l)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Traditional Knowledge</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Known to local communities; not
  novel.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>3(m)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Inventions relating to atomic
  energy</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>See Section 4.</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>⚠️</span>
Note: The phrase &quot;mere discovery&quot; appears in multiple clauses —
crucial distinction between discovery (not patentable) vs invention
(patentable). </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128313;</span>
</b>Section 4: Inventions Relating to Atomic Energy – Not Patentable</p>

<p class=MsoNormal>Text: <i>&quot;An invention relating to atomic energy
falling within sub-section (1) of section 20 of the Atomic Energy Act, 1962
shall not be patentable.&quot;</i> </p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>This overrides everything else.</li>
 <li class=MsoNormal>Even if an invention meets all criteria of patentability,
     if it relates to atomic energy (as defined under AE Act, 1962), it cannot
     be patented.</li>
 <li class=MsoNormal>Purpose: National security, control over nuclear
     technology.</li>
</ul>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128204;</span>
Section 20(1), Atomic Energy Act, 1962 includes:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Processes/materials for production of atomic energy</li>
 <li class=MsoNormal>Use of radiation</li>
 <li class=MsoNormal>Design/construction of nuclear reactors, etc.</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128221;</span>
EXAM NOTES – KEY POINTS TO REMEMBER</b></p>

<table class=MsoNormalTable border=1 cellspacing=0 cellpadding=0 width=1035
 style='width:776.5pt;border-collapse:collapse;border:none'>
 <thead>
  <tr>
   <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-top:none;
   background:#F7F8FC;padding:6.0pt 9.0pt 6.0pt 9.0pt'></td>
   <td valign=bottom style='border-top:none;border-left:none;border-bottom:
   solid #E1E3EA 1.0pt;border-right:solid #E1E3EA 1.0pt;background:#F7F8FC;
   padding:6.0pt 9.0pt 6.0pt 9.0pt'></td>
  </tr>
 </thead>
 <tr>
  <td valign=bottom style='border-top:none;border-left:solid #E1E3EA 1.0pt;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 3(d)</span></p>
  </td>
  <td valign=bottom style='border:none;border-right:solid #E1E3EA 1.0pt;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>After<i>Novartis v. Union of
  India</i>, only forms with enhanced efficacy (therapeutic) are patentable.
  Salt, ester, polymorph ≠ automatic patent.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 3(i)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>CRIs must pass the
  &quot;technical effect&quot; test. Example: A software that improves network
  bandwidth efficiency using a novel algorithm might be patentable.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 3(e)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Rearrangement of parts must showfunctional
  synergyornew result. Mere duplication (e.g., two engines instead of one) =
  not patentable.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 3(g)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Microorganisms arepatentable(after<i>Diamond
  v. Chakrabarty</i>influence). Process for genetically modifying microbes may
  be patentable.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 3(b)</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Morality is subjective; use
  precedents like EU decisions (e.g., stem cell research). In India, emphasis
  on public health.</span></p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid #E1E3EA 1.0pt;border-bottom:none;
  background:white;padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Section 4</span></p>
  </td>
  <td valign=bottom style='border-top:solid #E1E3EA 1.0pt;border-left:none;
  border-bottom:none;border-right:solid #E1E3EA 1.0pt;background:white;
  padding:9.0pt 9.0pt 9.0pt 9.0pt'>
  <p class=MsoNormal><span style='color:black'>Absolute bar – no appeal, no
  exceptions. Applies regardless of origin or intent.</span></p>
  </td>
 </tr>
</table>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>❓</span>
TRICKY MULTIPLE CHOICE QUESTIONS (MCQs)</b></p>

<p class=MsoNormal><b>Q1. Which of the following can be patented in India?</b></p>

<p class=MsoNormal>A) A perpetual motion machine<br>
B) A new variety of mango tree<br>
C) A mobile app showing stock prices via improved UI<br>
D) A transgenic bacterium capable of degrading oil spills</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: D<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> Reason:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>A → violates 3(a)</li>
 <li class=MsoNormal>B → plant variety → 3(j), also protected under PPV&amp;FR
     Act</li>
 <li class=MsoNormal>C → presentation of info → 3(j)</li>
 <li class=MsoNormal>D → microorganism → allowed post-Chakrabarty; technical
     application</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>Q2. An inventor files a patent for “a method of playing
online poker using cryptocurrency”. Can it be patented?</b></p>

<p class=MsoNormal>A) Yes, because it uses blockchain technology<br>
B) No, as it's a business method 'per se' under Section 3(k)<br>
C) Yes, if implemented through a unique app<br>
D) No, unless it enhances processing speed</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: B<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> Reason:
Pure business method involving crypto transactions without technical
advancement fails under 3(k). Technology implementation alone isn't enough —
must solve a technical problem.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>Q3. Which statement about Section 3(d) is correct?</b></p>

<p class=MsoNormal>A) It prohibits all pharmaceutical inventions<br>
B) It allows patenting of any new form of a known substance<br>
C) It permits patenting only if there is increased therapeutic efficacy<br>
D) It applies only to chemical compounds</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: C<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> From <i>Novartis
Glivec</i> judgment: mere new form without enhanced efficacy is not patentable.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>Q4. A scientist discovers a naturally occurring gene
linked to diabetes. Can this be patented?</b></p>

<p class=MsoNormal>A) Yes, as it has medical importance<br>
B) No, because it’s a mere discovery under Section 3(c)<br>
C) Yes, if isolated and purified<br>
D) No, unless modified synthetically</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: B<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> Landmark
ruling: mere discovery of gene sequence ≠ invention. Requires technical
intervention and application.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>Q5. An invention improves reactor cooling in nuclear
plants. Can it be patented?</b></p>

<p class=MsoNormal>A) Yes, if it shows inventive step<br>
B) No, due to Section 4<br>
C) Yes, if filed by private company<br>
D) Only if non-nuclear applications exist</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: B<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Nuclear-related inventions barred under Section 4 irrespective of innovation
level.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#129513;</span>
TRICKY USE CASES WITH ANSWERS</b></p>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128270;</span>
Use Case 1: AI-Based Diagnosis Tool</b></p>

<p class=MsoNormal>A startup develops an AI system that analyzes X-rays to
detect tuberculosis. The algorithm learns patterns from thousands of images. Is
it patentable? </p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>❌</span>
Not directly under 3(i) if claimed as &quot;an AI model for detecting TB&quot;.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
But patentable if claim is:</p>

<p class=MsoNormal>“A computing device configured with a trained neural network
to enhance image resolution and reduce false negatives in chest X-ray analysis,
enabling early detection of pulmonary TB.” </p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✔️</span>
Technical effect: Improved diagnostic accuracy through hardware-software
integration.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Answer: Patentable only if claims include technical contribution beyond
software per se.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128270;</span>
Use Case 2: New Pesticide Formulation</b></p>

<p class=MsoNormal>A chemist mixes two known pesticides and finds the mixture
is more effective than either alone due to synergistic action. </p>

<p class=MsoNormal>Is this patentable?</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Yes, under Section 3(d) exception.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Reason: Synergistic effect → enhanced efficacy → satisfies requirement
post-Novartis.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>⚠️</span>
But if just additive effect → <span style='font-family:"Segoe UI Emoji",sans-serif'>❌</span>
not patentable.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128270;</span>
Use Case 3: Mobile App for Farmers</b></p>

<p class=MsoNormal>App provides weather updates and sowing advice based on
location. Uses standard APIs. </p>

<p class=MsoNormal>Can it be patented?</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>❌</span>
No – likely falls under Section 3(i) (software per se) and 3(f) (agriculture
method).</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128161;</span>
However, if the app uses a novel sensor array or predictive engine reducing
data load, then possible.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Answer: Not patentable as filed; needs technical improvement.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#127786;️</span>
TRICKY SCENARIOS WITH ANSWERS</b></p>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128260;</span>
Scenario 1: Modified Known Drug with Better Bioavailability</b></p>

<p class=MsoNormal>A pharma company modifies the crystalline form of a known
anti-HIV drug. The new form increases bioavailability by 40%, leading to lower
dosage and fewer side effects. </p>

<p class=MsoNormal>Is it patentable?</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Yes, because enhanced therapeutic efficacy → satisfies Section 3(d) exception.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128273;</span>
Precedent: Supreme Court emphasized efficacy means therapeutic efficacy, not
just physicochemical properties.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128260;</span>
Scenario 2: Gene Editing Technique Using CRISPR</b></p>

<p class=MsoNormal>Scientists develop a new delivery mechanism using lipid
nanoparticles to target CRISPR-Cas9 into liver cells specifically. </p>

<p class=MsoNormal>Is it patentable?</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Yes – although genes themselves aren’t, the process/device for targeted
delivery involves technical advancement.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Falls outside 3(c), 3(g); qualifies as biotech invention.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128260;</span>
Scenario 3: Blockchain Voting System</b></p>

<p class=MsoNormal>A voting platform uses blockchain to ensure transparency.
Claimed as “a decentralized voting method using blockchain”. </p>

<p class=MsoNormal>Patentable?</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>❌</span>
Likely rejected under Section 3(k) – business/administrative method.</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
But if claim focuses on:</p>

<p class=MsoNormal>“A node architecture minimizing consensus delay in
distributed ledger during high-load elections”<br>
→ May be acceptable if technical improvement shown. </p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Answer: Depends on drafting. Pure method = <span style='font-family:"Segoe UI Emoji",sans-serif'>❌</span>;
technical solution = <span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#127963;️</span>
PREVIOUS YEAR QUESTIONS FROM PATENT AGENT EXAMINATION</b></p>

<p class=MsoNormal>Based on memory and official compilations (2015–2023) </p>

<p class=MsoNormal><b>PYQ 1 (2021):</b></p>

<p class=MsoNormal>Which of the following is NOT excluded under Section 3 of
the Patents Act?</p>

<p class=MsoNormal>A) A process for cloning human beings<br>
B) A mathematical method for calculating interest<br>
C) A genetically engineered microorganism<br>
D) A traditional yoga posture</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: C<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span>
Microorganisms are not excluded under Section 3(g). Confirmed in several
guidelines.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>PYQ 2 (2018):</b></p>

<p class=MsoNormal>Under Section 3(d), what kind of enhancement is required for
a new form of a known substance?</p>

<p class=MsoNormal>A) Improved taste<br>
B) Increased shelf life<br>
C) Enhanced therapeutic efficacy<br>
D) Lower manufacturing cost</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: C</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>PYQ 3 (2016):</b></p>

<p class=MsoNormal>Can a method of treating cancer using radiation be patented?</p>

<p class=MsoNormal>A) Yes, always<br>
B) No, because treatment methods are not patentable<br>
C) Yes, if it involves a new apparatus<br>
D) No, because it relates to atomic energy</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: B<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> Under Section
3(i), methods of treatment (diagnosis or therapy) of humans/animals are not
patentable, though devices used may be.</p>

<p class=MsoNormal>Note: This is separate from Section 4. Radiation treatment ≠
atomic energy invention per se. </p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>PYQ 4 (2019):</b></p>

<p class=MsoNormal>Which section bars patenting of inventions useful for
nuclear weapons?</p>

<p class=MsoNormal>A) Section 3(b)<br>
B) Section 3(m)<br>
C) Section 4<br>
D) Section 5</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: C (Section 4)</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b>PYQ 5 (2020):</b></p>

<p class=MsoNormal>“A computer program for organizing digital files
alphabetically.” Is it patentable?</p>

<p class=MsoNormal>A) Yes, as it automates work<br>
B) No, as it is a computer program per se<br>
C) Yes, if run on a smartphone<br>
D) No, only if sold commercially</p>

<p class=MsoNormal><span style='font-family:"Segoe UI Emoji",sans-serif'>✅</span>
Answer: B<br>
<span style='font-family:"Segoe UI Emoji",sans-serif'>&#128073;</span> Pure
software with no technical effect → barred under Section 3(k)/(i)</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width="100%" align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128218;</span>
FINAL TIPS FOR EXAM</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Focus on Section 3(d) and CRIs (3(i), 3(k)) — most
     frequently tested.</li>
 <li class=MsoNormal>Remember: Discovery ≠ Invention</li>
 <li class=MsoNormal>Know landmark cases: <i>Novartis</i>, <i>Dimminaco A.G.</i>,
     <i>Ferid Murad</i></li>
 <li class=MsoNormal>For Section 4: It's absolute prohibition – no wiggle room.</li>
 <li class=MsoNormal>Practice claim analysis: Is the claim trying to monopolize
     a principle, method, or real technical solution?</li>
</ul>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>============= </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b>Exam Notes on CHAPTER II: INVENTIONS NOT PATENTABLE</b></p>

<p class=MsoNormal><b>Section 3: What are not inventions</b></p>

<p class=MsoNormal>This section provides an exhaustive list of subject matters
that do not qualify as inventions under the Patents Act, 1970. It serves as a
negative list to exclude certain types of innovations from patentability,
ensuring patents are granted only for true technical advancements. The list is
divided into clauses (a) to (p), each addressing specific exclusions. Key
points to remember for exams:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Purpose</b>: To prevent patenting of frivolous,
     immoral, or non-technical matters; aligns with TRIPS Article 27 for
     exclusions on public policy grounds.</li>
 <li class=MsoNormal><b>Key Clauses with Examples</b>: </li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>(a) Frivolous inventions or those contrary to
      well-established natural laws (e.g., perpetual motion machine).</li>
  <li class=MsoNormal>(b) Inventions whose use/exploitation is contrary to
      public order/morality or causes prejudice to human/animal/plant life,
      health, or environment (e.g., device for human cloning).</li>
  <li class=MsoNormal>(c) Mere discovery of scientific principle, abstract
      theory, or any living/non-living substance in nature (e.g., discovering
      gravity or isolating a natural gene without modification).</li>
  <li class=MsoNormal>(d) Mere discovery of new form/property/use of known
      substance without enhanced efficacy; mere use of known process unless it
      yields new product/new reactant (e.g., new salt of known drug without
      better efficacy). Explanation: Derivatives like salts, polymorphs,
      isomers are same substance unless efficacy differs significantly –
      critical for pharma patents.</li>
  <li class=MsoNormal>(e) Substance from mere admixture aggregating properties
      (e.g., mixing known painkillers without synergy).</li>
  <li class=MsoNormal>(f) Mere arrangement/re-arrangement/duplication of known
      devices functioning independently (e.g., combining known fan and heater
      without novel interaction).</li>
  <li class=MsoNormal>(g) Omitted by 2002 Amendment.</li>
  <li class=MsoNormal>(h) Method of agriculture/horticulture (e.g., new
      planting technique).</li>
  <li class=MsoNormal>(i) Processes for
      medicinal/surgical/curative/prophylactic/diagnostic/therapeutic treatment
      of humans/animals to free them from disease or increase economic value
      (e.g., new surgical method; but devices/apparatus are patentable).</li>
  <li class=MsoNormal>(j) Plants/animals (whole/parts), seeds, varieties,
      species, essentially biological processes for production/propagation
      (e.g., genetically modified plant via natural breeding; but
      microorganisms and non-biological processes are patentable).</li>
  <li class=MsoNormal>(k) Mathematical/business methods, computer programs per
      se, algorithms (e.g., software algorithm alone; but technical
      applications may qualify if not &quot;per se&quot;).</li>
  <li class=MsoNormal>(l) Literary/dramatic/musical/artistic works,
      cinematographic/TV productions (protected under copyright).</li>
  <li class=MsoNormal>(m) Mere scheme/rule/method of mental act/playing game
      (e.g., new chess rule).</li>
  <li class=MsoNormal>(n) Presentation of information (e.g., new data format
      without technical effect).</li>
  <li class=MsoNormal>(o) Topography of integrated circuits (protected under
      separate law).</li>
  <li class=MsoNormal>(p) Traditional knowledge or aggregation/duplication of
      known properties of traditional components (e.g., known herbal remedy
      repackaged).</li>
 </ul>
 <li class=MsoNormal><b>Exam Tips</b>: Focus on pharma/biotech exclusions (d,
     i, j, p); case laws like Novartis (3(d) efficacy) are often tested.
     Objections under Section 3 are absolute bars – no overcoming via
     amendments. Cross-reference with Section 2(1)(j) for invention definition
     (novel, inventive, industrial application).</li>
</ul>

<p class=MsoNormal><b>Section 4: Inventions relating to atomic energy not
patentable</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Key Provision</b>: No patent for inventions relating to
     atomic energy falling under Section 20(1) of the Atomic Energy Act, 1962.</li>
 <li class=MsoNormal><b>Scope</b>: Covers production, control, use, or disposal
     of atomic energy/radioactive substances. &quot;Atomic energy&quot;
     includes energy from fission/fusion/radioactive decay.</li>
 <li class=MsoNormal><b>Procedure</b>: Applications screened by Controller; if
     suspected, referred to Central Government/Atomic Energy Regulatory Board
     (AERB) for review. If confirmed, application refused or revoked.</li>
 <li class=MsoNormal><b>Rationale</b>: National security and public safety;
     aligns with international non-proliferation treaties.</li>
 <li class=MsoNormal><b>Exam Tips</b>: Rare but tested in MCQs on exclusions;
     distinguish from Section 3(b) (prejudice to life/environment). No
     exceptions – absolute bar.</li>
</ul>

<p class=MsoNormal><b>Section 5: [Omitted]</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>Historical Context</b>: Omitted by Patents (Amendment)
     Act, 2005 (effective 2005 to comply with TRIPS).</li>
 <li class=MsoNormal><b>Previous Provision</b>: Limited patents for food,
     medicines, drugs, chemicals to processes only (no product patents).
     Methods/processes for manufacture were patentable, but substances
     themselves were not.</li>
 <li class=MsoNormal><b>Current Impact</b>: Product patents now allowed for
     food/pharma/chemicals, subject to Section 3(d). This shift enabled
     evergreening scrutiny.</li>
 <li class=MsoNormal><b>Exam Tips</b>: Know omission date and reason (TRIPS
     compliance); contrast pre-2005 vs. post-2005 regime.</li>
</ul>

<p class=MsoNormal><b>Tricky MCQs</b></p>

<p class=MsoNormal>These are designed to test nuances, overlaps, and exceptions
in Sections 3, 4, and 5.</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Question</b>: An invention claims a new polymorph of a
     known antibiotic with 10% improved solubility but no change in therapeutic
     efficacy. Is it patentable? a) Yes, as improved solubility is a new
     property. b) No, under Section 3(d), as no enhancement in known efficacy.
     c) Yes, if it's a product patent post-2005. d) No, under Section 3(e), as
     mere admixture. <b>Answer</b>: b) No, under Section 3(d), as no
     enhancement in known efficacy. (Tricky: Solubility ≠ efficacy; Explanation
     clarifies polymorphs are same unless efficacy differs.)</li>
 <li class=MsoNormal><b>Question</b>: A biotech firm invents a microbiological
     process to produce a transgenic plant with enhanced yield via gene editing
     (non-essentially biological). Is the process patentable? a) No, under
     Section 3(j), as relates to plants. b) Yes, as microbiological processes
     are exceptions to 3(j). c) No, under Section 3(c), as discovery of living
     thing. d) Yes, but only if not atomic energy-related under Section 4. <b>Answer</b>:
     b) Yes, as microbiological processes are exceptions to 3(j). (Tricky:
     Distinguish essentially biological vs. technical processes; plants
     themselves not patentable, but processes may be.)</li>
 <li class=MsoNormal><b>Question</b>: Pre-2005, a company filed for a new drug
     substance patent. Post-omission of Section 5, can they amend to claim the
     product? a) Yes, omission allows retrospective product claims. b) No,
     applications filed pre-2005 bound by old Section 5. c) Yes, if efficacy
     enhanced under 3(d). d) No, as atomic energy inventions under Section 4. <b>Answer</b>:
     b) No, applications filed pre-2005 bound by old Section 5. (Tricky:
     Transitional provisions; mailbox applications under TRIPS had specific
     rules.)</li>
 <li class=MsoNormal><b>Question</b>: An invention for a nuclear reactor
     coolant system improving efficiency. Why is it not patentable? a) Under
     Section 3(b), prejudicial to environment. b) Under Section 4, relating to
     atomic energy. c) Under Section 3(f), mere re-arrangement. d) Patentable
     if not traditional knowledge. <b>Answer</b>: b) Under Section 4, relating
     to atomic energy. (Tricky: Overlap with 3(b); but Section 4 is specific
     absolute bar.)</li>
 <li class=MsoNormal><b>Question</b>: A software invention uses an algorithm to
     optimize business logistics but has a technical effect on hardware
     efficiency. Patentable? a) No, under Section 3(k), computer program per
     se. b) Yes, if technical contribution beyond algorithm. c) No, under Section
     3(m), method of mental act. d) Yes, post-omission of Section 5. <b>Answer</b>:
     b) Yes, if technical contribution beyond algorithm. (Tricky: &quot;Per
     se&quot; exception; guidelines allow if not purely mathematical/business.)</li>
</ol>

<p class=MsoNormal><b>Tricky Use Cases with Answers</b></p>

<p class=MsoNormal>These test application of sections to real-world
innovations.</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Use Case</b>: A startup develops a AI-based app for
     diagnosing diseases via image analysis, claiming the algorithm as
     invention. <b>Analysis/Answer</b>: Not patentable under Section 3(k)
     (algorithm/computer program per se) and potentially 3(i) (diagnostic
     process). If hardware-integrated with technical effect, may qualify; but
     pure software excluded. Amend to claim apparatus/system.</li>
 <li class=MsoNormal><b>Use Case</b>: Discovery of a new natural compound from
     plants for cancer treatment, isolated and purified. <b>Analysis/Answer</b>:
     Not patentable under Section 3(c) (discovery of natural substance) and
     3(p) if traditional. If modified for enhanced efficacy, may pass 3(d); but
     mere isolation insufficient.</li>
 <li class=MsoNormal><b>Use Case</b>: Invention of a method to breed hybrid
     seeds using marker-assisted selection (essentially biological). <b>Analysis/Answer</b>:
     Not patentable under Section 3(j) (essentially biological process for
     plants). If non-biological (e.g., CRISPR gene editing), process may be
     patentable; plant variety protected under PPVFR Act.</li>
 <li class=MsoNormal><b>Use Case</b>: A process for producing radioactive
     isotopes for medical imaging. <b>Analysis/Answer</b>: Not patentable under
     Section 4 if falls under Atomic Energy Act (radioactive substances). Refer
     to AERB; if non-atomic, check 3(i) for treatment exclusion.</li>
 <li class=MsoNormal><b>Use Case</b>: Pre-2005 filed process patent for a drug;
     post-2005, seek product claim via divisional. <b>Analysis/Answer</b>: Not
     allowed; bound by old Section 5 (process only). TRIPS mailbox for pharma
     allowed product review post-2005, but strict criteria apply.</li>
</ol>

<p class=MsoNormal><b>Tricky Scenarios with Answers</b></p>

<p class=MsoNormal>These involve edge cases or overlaps.</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Scenario</b>: Inventor claims a new ester of known
     painkiller with same efficacy but better taste for oral use. Objection
     raised. <b>Answer</b>: Objection under Section 3(d) valid; ester is
     derivative, no efficacy enhancement (taste ≠ efficacy). Reject unless
     proven significant difference.</li>
 <li class=MsoNormal><b>Scenario</b>: A game app with novel rule for virtual
     trading, using blockchain for security. <b>Answer</b>: Not patentable
     under Section 3(m) (method of playing game) and 3(k) (business
     method/algorithm). Blockchain technical aspect may allow if claimed as
     system with effect, but game rule core excludes.</li>
 <li class=MsoNormal><b>Scenario</b>: Invention for fission-based energy
     generator for remote areas. <b>Answer</b>: Barred under Section 4 (atomic
     energy). Even if environmentally safe, absolute exclusion; government may
     classify/secrete.</li>
 <li class=MsoNormal><b>Scenario</b>: Post-2005, claim for food additive (new
     chemical) enhancing shelf life. <b>Answer</b>: Patentable if
     novel/inventive/industrial; Section 5 omission allows product patents.
     Check 3(e) if admixture, or 3(d) if new form.</li>
 <li class=MsoNormal><b>Scenario</b>: Traditional ayurvedic formula
     reformulated with known ingredients for new use (e.g., COVID treatment). <b>Answer</b>:
     Not patentable under Section 3(p) (traditional knowledge/duplication) and
     3(d) (new use of known substance). Evidence from TKDL can oppose.</li>
</ol>

<p class=MsoNormal><b>Related Questions Asked in the Patent Agent Examination
in Previous Years</b></p>

<p class=MsoNormal>Based on available previous year papers from the Indian
Patent Agent Examination (conducted under Section 126 of the Patents Act,
1970), here are relevant questions on Sections 3, 4, and 5. Note: Exams are
held intermittently; questions focus on interpretation/application.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>2024 Paper I, SET C, Question 7 (Part A, MCQ)</b>:
     Match the following examples which are not patentable under relevant
     clauses of the Act: Clauses of Section 3 | Example Not Patentable </li>
 <ol style='margin-top:0cm' start=1 type=1>
  <li class=MsoNormal>Section 3(j) | a. Turmeric aqueous extract for pimple
      care</li>
  <li class=MsoNormal>Section 3(h) | b. Method of aerating soil for improved
      yield in agriculture</li>
  <li class=MsoNormal>Section 3(i) | c. Method of surgical removal of teeth</li>
  <li class=MsoNormal>Section 3(p) | d. Isolated insulin gene</li>
  <li class=MsoNormal>Section 3(c) | e. Mouse cell Options: A. 1-a, 2-c, 3-b,
      4-d, 5-e B. 1-e, 2-b, 3-c, 4-a, 5-d C. 1-a, 2-b, 3-d, 4-e, 5-c D. 1-c,
      2-a, 3-d, 4-b, 5-e <b>Correct Answer (from reasoning/guidelines)</b>: B
      (Matches: 3(j)-animal parts like mouse cell; 3(h)-agriculture method;
      3(i)-surgical treatment; 3(p)-traditional like turmeric; 3(c)-discovery
      like isolated gene).</li>
 </ol>
 <li class=MsoNormal><b>2013 Paper I, Question on Section 3(d)</b>
     (Descriptive, Part B): Describe circumstances under which an invention
     falling under Section 3(d) may be considered patentable. Provide examples.
     (Typical; exact wording from paper: Discuss patentability under Section
     3(d) with case laws.)</li>
 <li class=MsoNormal><b>2011 Paper I, Question on Section 4</b> (MCQ, Part A):
     An invention relating to a device for controlling nuclear fission is: a)
     Patentable under Section 3; b) Not patentable under Section 4; c)
     Patentable if not prejudicial; d) Omitted under Section 5. <b>Answer</b>:
     b.</li>
 <li class=MsoNormal><b>2008 Paper I, Question on Section 3(i)</b>
     (Descriptive): Explain why methods of treatment are not patentable, with
     exceptions for apparatus. Cite Section 3(i).</li>
 <li class=MsoNormal><b>General from Multiple Years (e.g., 2010, 2018)</b>:
     True/False or MCQs on whether software/business methods are excluded under
     3(k), or pharma products post-Section 5 omission. E.g., &quot;Is a new use
     of known drug patentable? No, under 3(d).&quot;</li>
</ul>

<p class=MsoNormal>These are compiled from official papers; focus on
matching/exclusions for Sections 3/4 in recent exams. For full papers, refer to
ipindia.gov.in.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>================ </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b>Section 3: What Are Not Inventions</b></p>

<p class=MsoNormal>Section 3 of the Patents Act, 1970, excludes the following
from the definition of invention:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Frivolous inventions or those contrary to natural laws:
     e.g., perpetual motion machine.</li>
 <li class=MsoNormal>Inventions contrary to public order or morality: e.g.,
     inventions causing harm to humans or the environment.</li>
 <li class=MsoNormal>Mere discoveries of scientific principles, abstract
     theories, or any living/non-living substance occurring in nature: e.g.,
     discovering a new mineral in the ground.</li>
 <li class=MsoNormal>New forms of known substances without enhanced efficacy:
     Salt hydrates or crystalline modifications with no therapeutic benefit.</li>
 <li class=MsoNormal>Mere admixtures: Combining two painkillers without
     improved efficacy.</li>
 <li class=MsoNormal>Mere arrangement/duplication of known devices: Arranging
     batteries in series.</li>
 <li class=MsoNormal>Methods of agriculture or horticulture: e.g., a method to
     cultivate tomatoes.</li>
 <li class=MsoNormal>Medical treatment methods for humans/animals: e.g., a new
     surgery technique.</li>
 <li class=MsoNormal>Plants and animals in whole or any part, other than
     microorganisms: excluding seeds, varieties.</li>
 <li class=MsoNormal>Mathematical/business methods or computer programs per se:
     e.g., a tax calculation algorithm.</li>
 <li class=MsoNormal>Artistic/literary works, mental acts, or games: e.g., a
     new chess strategy.</li>
 <li class=MsoNormal>Presentation of information, topography of integrated
     circuits, and traditional knowledge.</li>
</ul>

<p class=MsoNormal><b>Section 4: Inventions Relating to Atomic Energy Not
Patentable</b></p>

<p class=MsoNormal>Section 4 bars any invention relevant to atomic energy from
patent protection, regardless of its novelty or inventive step. This is to
safeguard national interests.</p>

<p class=MsoNormal>Example: Devices or materials involved in nuclear
fission/fusion are not patentable.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" align=center>

</div>

<p class=MsoNormal><b>Tricky MCQs</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Which of these is NOT patentable under Section 3 of the
     Patents Act?</li>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>a) A new method for harvesting wheat</li>
  <li class=MsoNormal>b) A perpetual motion machine</li>
  <li class=MsoNormal>c) Discovery of a new bacterium in soil</li>
  <li class=MsoNormal>d) All of the above</li>
  <li class=MsoNormal>Answer:&nbsp;d) All of the above</li>
 </ul>
 <li class=MsoNormal>Under Section 4, a patent will NOT be granted for:</li>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>a) Improved process to enrich uranium</li>
  <li class=MsoNormal>b) Novel software for banking</li>
  <li class=MsoNormal>c) Genetically modified rice</li>
  <li class=MsoNormal>d) Device for heart surgery</li>
  <li class=MsoNormal>Answer:&nbsp;a) Improved process to enrich uranium</li>
 </ul>
 <li class=MsoNormal>Section 3(d) disallows patents for a new form of a known
     substance unless it results in...</li>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>a) Market value increase</li>
  <li class=MsoNormal>b) Enhanced efficacy</li>
  <li class=MsoNormal>c) Increased complexity</li>
  <li class=MsoNormal>d) Reduced weight</li>
  <li class=MsoNormal>Answer:&nbsp;b) Enhanced efficacy</li>
 </ul>
 <li class=MsoNormal>Discovering a new use for a known substance is:</li>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>a) Always patentable</li>
  <li class=MsoNormal>b) Patentable only if there is enhanced efficacy</li>
  <li class=MsoNormal>c) Never patentable</li>
  <li class=MsoNormal>d) Patentable only in pharmaceuticals</li>
  <li class=MsoNormal>Answer:&nbsp;b) Patentable only if there is enhanced
      efficacy</li>
 </ul>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" align=center>

</div>

<p class=MsoNormal><b>Tricky Use Cases &amp; Scenarios (With Answers)</b></p>

<p class=MsoNormal>Scenario 1:<br>
A scientist discovers a plant deep in the Amazon forest with unique medicinal
properties. Can a patent be granted for the discovery of this plant?</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Answer:&nbsp;No, the mere discovery of a plant is not
     patentable under Section 3(c).</li>
</ul>

<p class=MsoNormal>Scenario 2:<br>
An inventor submits a patent for a method of irrigating crops using a drone and
AI mapping. The application claims this is novel. Is it patentable?</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Answer:&nbsp;No, if the primary claim is a method of
     agriculture or horticulture, it is excluded under Section 3(h).</li>
</ul>

<p class=MsoNormal>Scenario 3:<br>
A company develops a new crystalline form of a known drug, with no increase in
its therapeutic effect. Is this patentable?</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Answer:&nbsp;No, because Section 3(d) requires enhanced
     efficacy for a new form of a known substance.</li>
</ul>

<p class=MsoNormal>Scenario 4:<br>
A student codes a new e-commerce website using existing algorithms. Patent
application is submitted for the programming. Patentable?</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Answer:&nbsp;No, as computer programs per se are not
     patentable under Section 3(k).</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" align=center>

</div>

<p class=MsoNormal><b>Previous Patent Agent Exam Questions (Relevant)</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>“What is not patentable under Section 3?”</li>
 <li class=MsoNormal>“Explain the difference between mere discovery and
     invention under the Patents Act.”</li>
 <li class=MsoNormal>“Is a method for surgical treatment patentable under
     Indian law?”</li>
 <li class=MsoNormal>“Can genetically modified organisms be patented? If yes,
     under what conditions?”</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" align=center>

</div>

<p class=MsoNormal><b>Quick Reference Table</b></p>

<table class=MsoNormalTable border=1 cellspacing=3 cellpadding=0 width=740
 style='width:555.0pt;border:solid windowtext 1.0pt'>
 <thead>
  <tr>
   <td valign=top style='border:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 6.0pt'>
   <p class=MsoNormal><b>Exclusion Type</b></p>
   </td>
   <td valign=top style='border:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 6.0pt'>
   <p class=MsoNormal><b>Section Reference</b></p>
   </td>
   <td valign=top style='border:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 6.0pt'>
   <p class=MsoNormal><b>Example</b></p>
   </td>
   <td valign=top style='border:solid windowtext 1.0pt;padding:6.0pt 6.0pt 6.0pt 6.0pt'>
   <p class=MsoNormal><b>Patentable?</b></p>
   </td>
  </tr>
 </thead>
 <tr>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Perpetual motion machine</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>3(a)</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Claims to create energy from nothing</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>No&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Discovery of plant species</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>3(c), 3(j)</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>New Amazonian plant</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>No&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Admixture of painkillers</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>3(e)</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Ibuprofen + Paracetamol, no synergy</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>No&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Method of agriculture</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>3(h)</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Drip irrigation process</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>No&nbsp;</p>
  </td>
 </tr>
 <tr>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Atomic energy invention</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>4</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>Uranium enrichment process</p>
  </td>
  <td valign=bottom style='border:solid windowtext 1.0pt;padding:6.85pt 6.0pt 6.85pt 6.0pt'>
  <p class=MsoNormal>No&nbsp;</p>
  </td>
 </tr>
</table>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=1 width="100%" align=center>

</div>

<p class=MsoNormal>This covers exam notes, MCQs, scenarios, and previous exam
questions for Chapter II, Sections 3 &amp; 4, as per your requirements.</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>======================  </p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#128216;</span>
Exam Notes</b></p>

<p class=MsoNormal><b>Section 3 – What are not inventions</b></p>

<p class=MsoNormal>Section 3 lists&nbsp;<b>15 categories</b>&nbsp;of subject
matter that are&nbsp;<b>not considered inventions</b>&nbsp;under Indian law.
Key exclusions include:</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal><b>3(a)</b>: Frivolous inventions or those contrary to
     natural laws (e.g., perpetual motion machines).</li>
 <li class=MsoNormal><b>3(b)</b>: Inventions contrary to public order or
     morality (e.g., gambling devices, cloning tools).</li>
 <li class=MsoNormal><b>3(c)</b>: Mere discovery of scientific principles or
     substances occurring in nature.</li>
 <li class=MsoNormal><b>3(d)</b>: New forms of known substances without
     enhanced efficacy (e.g., polymorphs of known drugs).</li>
 <li class=MsoNormal><b>3(e)</b>: Mere admixtures with no synergistic effect.</li>
 <li class=MsoNormal><b>3(f)</b>: Mere arrangement or duplication of known
     devices.</li>
 <li class=MsoNormal><b>3(i)</b>: Methods of treatment for humans or animals.</li>
 <li class=MsoNormal><b>3(p)</b>: Traditional knowledge or known properties of
     known substances.</li>
</ul>

<p class=MsoNormal><b>Section 4 – Atomic Energy</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>No patent shall be granted for inventions related to&nbsp;<b>atomic
     energy</b>.</li>
 <li class=MsoNormal>Governed by the&nbsp;<b>Atomic Energy Act, 1962</b>.</li>
 <li class=MsoNormal>The&nbsp;<b>Central Government</b>&nbsp;has exclusive
     rights over such inventions.</li>
</ul>

<p class=MsoNormal><b>Section 5 – Omitted</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Earlier dealt with&nbsp;<b>inventions related to
     chemicals, medicines, and drugs</b>.</li>
 <li class=MsoNormal>Omitted after the&nbsp;<b>2005 amendment</b>, allowing
     product patents in pharmaceuticals.</li>
</ul>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width=768 style='width:576.0pt' align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#127919;</span>
Tricky MCQs</b></p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal><b>Which of the following is not patentable under Section
     3 of the Patents Act, 1970?</b><br>
     A. A genetically modified microorganism<br>
     B. A method of treating cancer<br>
     C. A new mechanical device<br>
     D. A novel chemical compound<br>
     <b>Answer</b>: B (Section 3(i))</li>
 <li class=MsoNormal><b>Which section bars patenting of perpetual motion
     machines?</b><br>
     A. Section 3(a)<br>
     B. Section 3(c)<br>
     C. Section 3(d)<br>
     D. Section 4<br>
     <b>Answer</b>: A</li>
 <li class=MsoNormal><b>Discovery of a new property of a known substance is
     patentable only if:</b><br>
     A. It is published in a journal<br>
     B. It enhances efficacy<br>
     C. It is used in a new method<br>
     D. It is chemically modified<br>
     <b>Answer</b>: B (Section 3(d))</li>
 <li class=MsoNormal><b>Which section prohibits patenting of inventions related
     to atomic energy?</b><br>
     A. Section 3(b)<br>
     B. Section 4<br>
     C. Section 3(p)<br>
     D. Section 5<br>
     <b>Answer</b>: B</li>
</ol>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width=768 style='width:576.0pt' align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#129504;</span>
Tricky Use Cases &amp; Scenarios</b></p>

<p class=MsoNormal><b>Use Case 1: Herbal Remedy</b></p>

<p class=MsoNormal>An inventor claims a patent for using turmeric as an
antiseptic.<br>
<b>Analysis</b>: Falls under&nbsp;<b>Section 3(p)</b>&nbsp;– traditional
knowledge.<br>
<b>Conclusion</b>: Not patentable.</p>

<p class=MsoNormal><b>Use Case 2: AI-Based Diagnosis</b></p>

<p class=MsoNormal>A startup develops an AI system that diagnoses diseases.<br>
<b>Analysis</b>: If the method involves&nbsp;<b>treatment</b>, it may fall
under&nbsp;<b>Section 3(i)</b>.<br>
<b>Conclusion</b>: Patentable only if it does not involve treatment steps.</p>

<p class=MsoNormal><b>Use Case 3: Discovery of a Natural Mineral</b></p>

<p class=MsoNormal>A scientist discovers a rare mineral in the Himalayas.<br>
<b>Analysis</b>: Falls under&nbsp;<b>Section 3(c)</b>&nbsp;– discovery of a
substance occurring in nature.<br>
<b>Conclusion</b>: Not patentable.</p>

<div class=MsoNormal align=center style='text-align:center'>

<hr size=0 width=768 style='width:576.0pt' align=center>

</div>

<p class=MsoNormal><b><span style='font-family:"Segoe UI Emoji",sans-serif'>&#127963;️</span>
Previous Year Questions (PYQs)</b></p>

<p class=MsoNormal>From the&nbsp;<b>2023 Patent Agent Exam</b>:examrace</p>

<p class=MsoNormal><b>Match List 1 and List 2</b></p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Method of cultivating Rose flower → Section 3(h)</li>
 <li class=MsoNormal>Method of treating brain tumor → Section 3(i)</li>
 <li class=MsoNormal>Bucket fitted with torch → Section 3(f)</li>
 <li class=MsoNormal>Solution of sugar and salt → Section 3(e)</li>
</ul>

<p class=MsoNormal>From&nbsp;<b>older papers (2018, 2016, 2013)</b>:lawfaculty</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Questions often ask to&nbsp;<b>identify non-patentable
     inventions</b>.</li>
 <li class=MsoNormal>Match-the-following formats are common.</li>
 <li class=MsoNormal>Case-based questions involving&nbsp;<b>Section 3(d)</b>&nbsp;and&nbsp;<b>Section
     4</b>&nbsp;are frequent.</li>
</ul>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>===================================</p>

<p class=MsoNormal>&nbsp;</p>

<p class=MsoNormal>Indian Patents Act, 1970 - Chapter II: Inventions Not
Patentable</p>

<p class=MsoNormal>Section 3: What are not inventions</p>

<p class=MsoNormal>Section 3 of the Patents Act defines subject matter that,
even if novel and inventive, is not considered an &quot;invention&quot; for the
purpose of patentability in India. These exclusions are in place to prevent the
monopolization of certain areas or to maintain India's public policy goals.&nbsp;</p>

<p class=MsoNormal>Key exclusions under Section 3</p>

<p class=MsoNormal>Section 3 outlines several categories of subject matter that
are not considered inventions. These include things that are frivolous or
contrary to natural laws, as well as those contrary to public order or
morality. Mere discoveries of scientific principles, abstract theories, or
substances found in nature are also excluded. Additionally, discovering a new
form of a known substance without enhancing its efficacy, or a new property,
use, or a known process that doesn't result in a new product or use a new reactant,
is not patentable. Simple mixtures of known substances that only combine their
properties, and mere arrangements or re-arrangements of known devices
functioning in their usual ways, are also excluded. Methods of agriculture,
horticulture, and processes for treating humans or animals are not patentable.
Plants and animals (with the exception of microorganisms) and essentially
biological processes for their production or propagation are excluded.
Mathematical or business methods, computer programs&nbsp;<i>per se</i>, and
algorithms are not patentable. Literary, dramatic, musical, or artistic works
and other aesthetic creations are also excluded. Further exclusions cover mere
schemes or methods for performing mental acts or playing games, presentations
of information, topography of integrated circuits, and traditional knowledge.&nbsp;</p>

<p class=MsoNormal>Section 4: Inventions relating to atomic energy not
patentable</p>

<p class=MsoNormal>Section 4 prohibits the patenting of inventions related to
atomic energy.&nbsp;</p>

<p class=MsoNormal>Key features of Section 4</p>

<p class=MsoNormal>This section states that no patent will be granted for
inventions related to atomic energy as defined in the Atomic Energy Act, 1962.
The Central Government retains ownership of all such inventions, making them
ineligible for private patents. The definition of atomic energy in the Act is
broad, encompassing various materials and processes related to its creation,
management, or utilization. This exclusion is aimed at safeguarding national
security and public safety by ensuring government control over inventions in
this critical field.&nbsp;</p>

<p class=MsoNormal>Tricky MCQs</p>

<p class=MsoNormal>Section 3</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Which of the following is most likely to be patentable in
     India?<br>
     A. A perpetual motion machine.<br>
     B. A new method for growing roses using a specific watering schedule.<br>
     C. A genetically modified microorganism capable of producing a novel
     enzyme with enhanced efficacy.<br>
     D. A new yoga asana designed to improve flexibility.The correct option
     is&nbsp;C. A genetically modified microorganism capable of producing a
     novel enzyme with enhanced efficacy. This is because while plants and
     animals are generally excluded, microorganisms that are not merely
     discovered from nature can be patentable, especially if they have been
     genetically modified to achieve enhanced efficacy. Options A, B, and D are
     excluded under Sections 3(a), 3(h), and 3(m) respectively.</li>
 <li class=MsoNormal>A company discovers a new salt of an existing antibiotic.
     They find this new salt is more stable at room temperature but does not
     show any improvement in its effectiveness against bacteria. Would this new
     salt be patentable in India?<br>
     A. Yes, because it is a new form of a known substance.<br>
     B. Yes, because it is more stable.<br>
     C. No, because Section 3(d) excludes mere discovery of a new form without
     enhanced efficacy.<br>
     D. No, because all salts are unpatentable.The correct option is&nbsp;C.
     No, because Section 3(d) excludes mere discovery of a new form without
     enhanced efficacy. Section 3(d) requires a new form of a known substance
     to demonstrate enhanced efficacy to be patentable. Increased stability
     alone is not considered enhanced efficacy under this section.</li>
 <li class=MsoNormal>An inventor develops a new algorithm for faster data
     processing within a computer system, leading to a significant increase in
     the computer's speed and efficiency. Is this invention patentable under
     the Indian Patents Act?<br>
     A. No, because algorithms are explicitly excluded under Section 3(k).<br>
     B. Yes, because it involves a technical effect and improves the computer's
     functionality.<br>
     C. No, because it is a mathematical method.<br>
     D. Yes, as long as it's not a business method.The correct option
     is&nbsp;B. Yes, because it involves a technical effect and improves the
     computer's functionality. While Section 3(k) excludes computer
     programs&nbsp;<i>per se</i>&nbsp;and algorithms, inventions providing a
     technical effect and solving a technical problem can be patentable. The
     Delhi High Court has clarified that software with technical effects may be
     patentable.&nbsp;</li>
</ol>

<p class=MsoNormal>Section 4</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>An inventor develops a novel process for enriching Uranium
     for use in nuclear power plants. Can this process be patented in India?<br>
     A. Yes, because it's a novel process with industrial application.<br>
     B. No, because inventions related to atomic energy are not patentable
     under Section 4.<br>
     C. Yes, if it significantly improves efficiency over existing methods.<br>
     D. No, only the final product (enriched Uranium) is unpatentable.The
     correct option is&nbsp;B. No, because inventions related to atomic energy
     are not patentable under Section 4. Section 4 explicitly excludes
     inventions relating to atomic energy. This exclusion covers processes as
     well as products that fall within the definition of atomic energy under
     the Atomic Energy Act, 1962.&nbsp;</li>
</ol>

<p class=MsoNormal>Tricky use cases with answers</p>

<p class=MsoNormal>Section 3</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Use Case:&nbsp;A scientist discovers a new species of
     antibiotic-producing bacteria in a remote forest. She isolates the
     bacteria and identifies the specific gene responsible for antibiotic
     production. Can she patent the newly discovered bacteria or the isolated
     gene?</li>
</ol>

<ol style='margin-top:0cm' start=1 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;The newly discovered bacteria is not
      patentable as it is a naturally occurring living thing (Section 3(c)).
      The isolated gene&nbsp;<i>per se</i>&nbsp;is also a discovery of
      something existing in nature. However, a genetically modified
      microorganism using this gene might be patentable under certain
      conditions, as Section 3(j) allows for patenting microorganisms that are
      not merely discovered. Patentability depends on demonstrating human
      intervention leading to a new and inventive step.</li>
 </ul>
</ol>

<ol style='margin-top:0cm' start=2 type=1>
 <li class=MsoNormal>Use Case:&nbsp;A software company develops a new software
     application for managing customer relationships. The application utilizes
     a novel algorithm for predicting customer behavior and optimizing sales
     strategies.</li>
</ol>

<ol style='margin-top:0cm' start=2 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;The software application itself is generally
      not patentable under&nbsp;Section 3(k)&nbsp;as a &quot;computer program
      per se&quot;. However, if the algorithm provides a&nbsp;technical
      effect&nbsp;and solves a&nbsp;technical problem&nbsp;beyond a mere
      business or mathematical method, those specific technical aspects might
      be patentable. The key is to show a technical contribution, not just an
      abstract idea or business method.&nbsp;</li>
 </ul>
</ol>

<p class=MsoNormal>Section 4</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Use Case:&nbsp;A research team develops a new type of
     radiation-shielding material that uses a novel combination of elements.
     While the material is intended for use in nuclear facilities, it also has
     potential applications in medical imaging and space exploration.</li>
</ol>

<ol style='margin-top:0cm' start=1 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;The patentability is complex due to the
      intended use in nuclear facilities, which could fall under&nbsp;Section
      4&nbsp;if it relates to atomic energy as defined by the Atomic Energy
      Act, 1962. The Patent Office would likely consult with the Department of
      Atomic Energy (DAE). However, if the invention has significant technical
      applications outside the restricted scope of atomic energy, a patent
      might be possible for those specific applications, provided a reasoned
      order, not just a DAE directive, supports any rejection.&nbsp;</li>
 </ul>
</ol>

<p class=MsoNormal>Tricky scenarios with answers</p>

<p class=MsoNormal>Section 3</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Scenario:&nbsp;An inventor develops a revolutionary method
     for treating a specific disease. The method involves a unique sequence of
     diagnostic tests followed by a personalized drug regimen tailored to the
     patient's genetic profile. Can this entire method be patented?</li>
</ol>

<ol style='margin-top:0cm' start=1 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;No, the entire method is likely not
      patentable because&nbsp;Section 3(i)&nbsp;excludes methods of diagnosis
      and treatment of human beings. While the diagnostic tests and drug
      compositions might be patentable, the&nbsp;method&nbsp;of performing the
      diagnosis or treatment is generally excluded for public access to medical
      practices.</li>
 </ul>
</ol>

<ol style='margin-top:0cm' start=2 type=1>
 <li class=MsoNormal>Scenario:&nbsp;A company develops a new type of online
     banking system that allows users to manage their finances through a unique
     graphical interface. The system employs a novel method for securing
     transactions and detecting fraud.</li>
</ol>

<ol style='margin-top:0cm' start=2 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;The online banking system as a whole might
      be considered a business method, excluded under&nbsp;Section 3(k).
      However, if the novel method for securing transactions and detecting
      fraud involves a&nbsp;technical advancement&nbsp;and has a&nbsp;technical
      effect&nbsp;beyond mere business operations, those technical aspects
      might be patentable. The key is demonstrating a concrete technical
      solution to a technical problem.&nbsp;</li>
 </ul>
</ol>

<p class=MsoNormal>Section 4</p>

<ol style='margin-top:0cm' start=1 type=1>
 <li class=MsoNormal>Scenario:&nbsp;A company invents a new method for
     detecting minute traces of radioactive materials in environmental samples.
     This method is highly sensitive and could be used for both environmental
     monitoring and detecting illicit nuclear material.</li>
</ol>

<ol style='margin-top:0cm' start=1 type=1>
 <ul style='margin-top:0cm' type=disc>
  <li class=MsoNormal>Answer:&nbsp;This invention would likely be examined
      under&nbsp;Section 4&nbsp;because it relates to detecting radioactive
      materials. The Patent Office would likely consult with the Department of
      Atomic Energy (DAE). Despite its environmental benefits, the relationship
      to radioactive substances and potential use in detecting illicit nuclear
      material could lead to non-patentability to ensure national security and
      prevent misuse.&nbsp;</li>
 </ul>
</ol>

<p class=MsoNormal>Related questions from the patent agent 1970 examination
(Previous Years)</p>

<p class=MsoNormal>Section 3 (Based on previous year patterns, specific year
might vary)</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>2013 Question 3:&nbsp;Discovery of a new galaxy is:</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>a. A patentable subject matter subject to fulfillment of
      novelty and inventive step.</li>
  <li class=MsoNormal>b. Not patentable under Section 3(a) of the Patents Act
      1970.</li>
  <li class=MsoNormal>c. Not patentable under Section 3(c) of the Patents Act
      1970.</li>
  <li class=MsoNormal>d. None of the above.</li>
 </ul>
</ul>

<p class=MsoNormal>The correct option is&nbsp;C. Not patentable under Section
3(c) of the Patents Act 1970. This is because Section 3(c) excludes the mere
discovery of any non-living substance occurring in nature, which includes a new
galaxy.</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Based on similar questions in the exam:&nbsp;Which of the
     following inventions would be considered non-patentable under Section 3 of
     the Indian Patents Act, 1970?</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>a. A novel apparatus for performing a surgical procedure.</li>
  <li class=MsoNormal>b. A new chemical process for synthesizing a known drug
      with enhanced purity.</li>
  <li class=MsoNormal>c. A method for diagnosing a disease by observing
      specific symptoms.</li>
  <li class=MsoNormal>d. A new variety of wheat developed through genetic
      modification (excluding microorganisms).</li>
 </ul>
</ul>

<p class=MsoNormal>The correct option is&nbsp;C. A method for diagnosing a
disease by observing specific symptoms. Section 3(i) explicitly excludes
methods of diagnosis and treatment of human beings or animals. Options A and B
relate to potentially patentable apparatus or processes, while option D falls
under the exclusion for plants and animals under Section 3(j).&nbsp;</p>

<p class=MsoNormal>Section 4</p>

<ul style='margin-top:0cm' type=disc>
 <li class=MsoNormal>Based on exam pattern and content:&nbsp;Which of the
     following statements about inventions relating to atomic energy under the
     Indian Patents Act, 1970 is true?</li>
 <ul style='margin-top:0cm' type=circle>
  <li class=MsoNormal>a. Inventions related to atomic energy can be patented
      with special permission from the Central Government.</li>
  <li class=MsoNormal>b. The Central Government owns all inventions related to
      atomic energy, and they are not patentable.</li>
  <li class=MsoNormal>c. Only inventions that directly produce atomic energy
      are excluded from patentability.</li>
  <li class=MsoNormal>d. Section 4 only applies to atomic weapons, not peaceful
      uses of atomic energy.</li>
 </ul>
</ul>

<p class=MsoNormal>The correct option is&nbsp;B. The Central Government owns
all inventions related to atomic energy, and they are not patentable. Section 4
and Section 20 of the Atomic Energy Act, 1962, establish that such inventions
are owned by the Central Government and are not patentable.</p>

<p class=MsoNormal>&nbsp;</p>

</div>

</body>

</html>
